{"id":8086,"date":"2024-03-19T13:10:09","date_gmt":"2024-03-19T13:10:09","guid":{"rendered":"https:\/\/www.optima-oncology.eu\/sorties\/"},"modified":"2024-11-28T10:34:57","modified_gmt":"2024-11-28T10:34:57","slug":"sorties-optima-en-bref","status":"publish","type":"page","link":"https:\/\/www.optima-oncology.eu\/fr\/sorties-optima-en-bref\/","title":{"rendered":"Sorties &#8211; OPTIMA en bref"},"content":{"rendered":"<p>[et_pb_section fb_built=\u00a0\u00bb1&Prime; admin_label=\u00a0\u00bbHeader  \u00a0\u00bb module_id=\u00a0\u00bbsection001bgs\u00a0\u00bb _builder_version=\u00a0\u00bb4.23.1&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb background_image=\u00a0\u00bbhttps:\/\/www.optima-oncology.eu\/wp-content\/uploads\/bg-ellipse-wp-section-001.svg\u00a0\u00bb background_size=\u00a0\u00bbinitial\u00a0\u00bb background_position=\u00a0\u00bbcenter_left\u00a0\u00bb min_height=\u00a0\u00bb440px\u00a0\u00bb min_height_tablet=\u00a0\u00bb355px\u00a0\u00bb min_height_phone=\u00a0\u00bb\u00a0\u00bb min_height_last_edited=\u00a0\u00bbon|tablet\u00a0\u00bb height=\u00a0\u00bb440px\u00a0\u00bb height_tablet=\u00a0\u00bb355px\u00a0\u00bb height_phone=\u00a0\u00bb\u00a0\u00bb height_last_edited=\u00a0\u00bbon|tablet\u00a0\u00bb max_height_tablet=\u00a0\u00bb355px\u00a0\u00bb max_height_phone=\u00a0\u00bb\u00a0\u00bb max_height_last_edited=\u00a0\u00bbon|tablet\u00a0\u00bb custom_padding=\u00a0\u00bb||12px|||\u00a0\u00bb da_popup_slug=\u00a0\u00bbsection001bgs\u00a0\u00bb da_disable_devices=\u00a0\u00bboff|off|off\u00a0\u00bb collapsed=\u00a0\u00bbon\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb da_is_popup=\u00a0\u00bboff\u00a0\u00bb da_exit_intent=\u00a0\u00bboff\u00a0\u00bb da_has_close=\u00a0\u00bbon\u00a0\u00bb da_alt_close=\u00a0\u00bboff\u00a0\u00bb da_dark_close=\u00a0\u00bboff\u00a0\u00bb da_not_modal=\u00a0\u00bbon\u00a0\u00bb da_is_singular=\u00a0\u00bboff\u00a0\u00bb da_with_loader=\u00a0\u00bboff\u00a0\u00bb da_has_shadow=\u00a0\u00bbon\u00a0\u00bb][et_pb_row _builder_version=\u00a0\u00bb4.16&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb width=\u00a0\u00bb70%\u00a0\u00bb custom_margin=\u00a0\u00bb||||false|false\u00a0\u00bb custom_margin_tablet=\u00a0\u00bb||60px||false|false\u00a0\u00bb custom_margin_phone=\u00a0\u00bb||60px||false|false\u00a0\u00bb custom_margin_last_edited=\u00a0\u00bbon|tablet\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_column type=\u00a0\u00bb4_4&Prime; _builder_version=\u00a0\u00bb4.16&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_text module_class=\u00a0\u00bbh1bug\u00a0\u00bb _builder_version=\u00a0\u00bb4.23.1&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb header_font=\u00a0\u00bb|800|||||||\u00a0\u00bb header_font_size=\u00a0\u00bb58px\u00a0\u00bb header_line_height=\u00a0\u00bb1.2em\u00a0\u00bb header_4_line_height=\u00a0\u00bb1.3em\u00a0\u00bb custom_margin=\u00a0\u00bb28px||||false|false\u00a0\u00bb header_font_size_tablet=\u00a0\u00bb24px\u00a0\u00bb header_font_size_phone=\u00a0\u00bb\u00a0\u00bb header_font_size_last_edited=\u00a0\u00bbon|tablet\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<h1>Sorties<\/h1>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=\u00a0\u00bb1&Prime; admin_label=\u00a0\u00bbIntegration Factsheets &#038; Overview\u00a0\u00bb _builder_version=\u00a0\u00bb4.23.1&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb custom_padding=\u00a0\u00bb||101px|||\u00a0\u00bb da_disable_devices=\u00a0\u00bboff|off|off\u00a0\u00bb collapsed=\u00a0\u00bboff\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb da_is_popup=\u00a0\u00bboff\u00a0\u00bb da_exit_intent=\u00a0\u00bboff\u00a0\u00bb da_has_close=\u00a0\u00bbon\u00a0\u00bb da_alt_close=\u00a0\u00bboff\u00a0\u00bb da_dark_close=\u00a0\u00bboff\u00a0\u00bb da_not_modal=\u00a0\u00bbon\u00a0\u00bb da_is_singular=\u00a0\u00bboff\u00a0\u00bb da_with_loader=\u00a0\u00bboff\u00a0\u00bb da_has_shadow=\u00a0\u00bbon\u00a0\u00bb][et_pb_row _builder_version=\u00a0\u00bb4.23.1&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_column type=\u00a0\u00bb4_4&Prime; _builder_version=\u00a0\u00bb4.23.1&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_text _builder_version=\u00a0\u00bb4.23.1&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb header_2_font=\u00a0\u00bb|700|||||||\u00a0\u00bb header_2_text_align=\u00a0\u00bbcenter\u00a0\u00bb header_2_line_height=\u00a0\u00bb120%\u00a0\u00bb header_4_line_height=\u00a0\u00bb1.3em\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<h2>OPTIMA en bref<\/h2>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00a0\u00bb4.16&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb width=\u00a0\u00bb70%\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_column type=\u00a0\u00bb4_4&Prime; _builder_version=\u00a0\u00bb4.16&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_text _builder_version=\u00a0\u00bb4.23.1&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb text_font_size=\u00a0\u00bb32px\u00a0\u00bb text_line_height=\u00a0\u00bb48px\u00a0\u00bb header_text_align=\u00a0\u00bbcenter\u00a0\u00bb header_2_text_align=\u00a0\u00bbleft\u00a0\u00bb custom_padding=\u00a0\u00bb0px||||false|false\u00a0\u00bb text_font_size_tablet=\u00a0\u00bb16px\u00a0\u00bb text_font_size_phone=\u00a0\u00bb\u00a0\u00bb text_font_size_last_edited=\u00a0\u00bbon|tablet\u00a0\u00bb text_line_height_tablet=\u00a0\u00bb24px\u00a0\u00bb text_line_height_phone=\u00a0\u00bb\u00a0\u00bb text_line_height_last_edited=\u00a0\u00bbon|tablet\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<p>Vous souhaitez en savoir plus sur OPTIMA ? Obtenez des informations br\u00e8ves mais concises dans notre <a title=\"Fiche d\u2019information - OPTIMA en un coup d\u2019\u0153il\" href=\"https:\/\/www.optima-oncology.eu\/fr\/sorties-optima-en-un-coup-doeil-revolutionner-loncologie\/\">fiche d\u2019information &#8211; OPTIMA en un coup d\u2019\u0153il<\/a>, qui pr\u00e9sente toutes les informations cl\u00e9s, ou lisez plus en d\u00e9tail nos documents de synth\u00e8se pr\u00e9par\u00e9s pour le public d\u2019experts (<a title=\"Vue d\u2019ensemble \u2013 Principes et objectifs cl\u00e9s\" href=\"https:\/\/www.optima-oncology.eu\/fr\/resultats-fiches-dinformation-et-vue-densemble\/\">Vue d\u2019ensemble &#8211; Principes et objectifs cl\u00e9s<\/a>) ou dans un langage accesible, destin\u00e9 aux patients (<a title=\"Vue d\u2019ensemble - pour les patients\" href=\"https:\/\/www.optima-oncology.eu\/fr\/vue-densemble-doptima-pour-les-patients\/\">Vue d\u2019ensemble &#8211; pour les patients<\/a>) ou pour en savoir plus sur l&rsquo;utilisation de l&rsquo;intelligence artificielle (IA) au sein d&rsquo;OPTIMA (<a title=\"IA Note explicative\" href=\"https:\/\/www.optima-oncology.eu\/fr\/resultats-intelligence-artificielle-ia-explicative\/\">IA Note explicative<\/a>).<\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=\u00a0\u00bb1&Prime; admin_label=\u00a0\u00bbVideo Library\u00a0\u00bb _builder_version=\u00a0\u00bb4.23.1&Prime; custom_padding=\u00a0\u00bb0px|||||\u00a0\u00bb bottom_divider_color=\u00a0\u00bb#2B318A\u00a0\u00bb da_disable_devices=\u00a0\u00bboff|off|off\u00a0\u00bb saved_tabs=\u00a0\u00bball\u00a0\u00bb collapsed=\u00a0\u00bboff\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb da_is_popup=\u00a0\u00bboff\u00a0\u00bb da_exit_intent=\u00a0\u00bboff\u00a0\u00bb da_has_close=\u00a0\u00bbon\u00a0\u00bb da_alt_close=\u00a0\u00bboff\u00a0\u00bb da_dark_close=\u00a0\u00bboff\u00a0\u00bb da_not_modal=\u00a0\u00bbon\u00a0\u00bb da_is_singular=\u00a0\u00bboff\u00a0\u00bb da_with_loader=\u00a0\u00bboff\u00a0\u00bb da_has_shadow=\u00a0\u00bbon\u00a0\u00bb][et_pb_row _builder_version=\u00a0\u00bb4.16&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_column type=\u00a0\u00bb4_4&Prime; _builder_version=\u00a0\u00bb4.16&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_text _builder_version=\u00a0\u00bb4.23.1&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb header_2_font=\u00a0\u00bb|700|||||||\u00a0\u00bb header_2_text_align=\u00a0\u00bbcenter\u00a0\u00bb header_2_line_height=\u00a0\u00bb120%\u00a0\u00bb header_4_line_height=\u00a0\u00bb1.3em\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<h2>Vid\u00e9oth\u00e8que<\/h2>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00a0\u00bb3_5,2_5&Prime; admin_label=\u00a0\u00bbOPTIMA oncology project introduction\u00a0\u00bb _builder_version=\u00a0\u00bb4.23.1&Prime; background_size=\u00a0\u00bbinitial\u00a0\u00bb background_position=\u00a0\u00bbtop_left\u00a0\u00bb background_repeat=\u00a0\u00bbrepeat\u00a0\u00bb custom_margin=\u00a0\u00bb||||false|false\u00a0\u00bb custom_margin_tablet=\u00a0\u00bb||60px||false|false\u00a0\u00bb custom_margin_phone=\u00a0\u00bb||60px||false|false\u00a0\u00bb custom_margin_last_edited=\u00a0\u00bbon|tablet\u00a0\u00bb collapsed=\u00a0\u00bbon\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_column type=\u00a0\u00bb3_5&Prime; _builder_version=\u00a0\u00bb4.16&Prime; custom_padding=\u00a0\u00bb|||\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb custom_padding__hover=\u00a0\u00bb|||\u00a0\u00bb][et_pb_text _builder_version=\u00a0\u00bb4.23.1&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb header_3_line_height=\u00a0\u00bb1.1em\u00a0\u00bb header_4_line_height=\u00a0\u00bb1.3em\u00a0\u00bb custom_margin=\u00a0\u00bb0px||||false|false\u00a0\u00bb custom_padding=\u00a0\u00bb0px||||false|false\u00a0\u00bb header_3_line_height_tablet=\u00a0\u00bb1.1em\u00a0\u00bb header_3_line_height_phone=\u00a0\u00bb1.1em\u00a0\u00bb header_3_line_height_last_edited=\u00a0\u00bbon|tablet\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<h3>Pr\u00e9sentation du projet OPTIMA en oncologie<\/h3>\n<p>OPTIMA (Optimal Treatment for Patients with Solid Tumours in Europe Through Artificial intelligence) est un programme de recherche public-priv\u00e9 dot\u00e9 de 21,3 millions d\u2019euros qui cherchera \u00e0 utiliser l\u2019intelligence artificielle (IA) pour am\u00e9liorer la prise en charge des patients atteints de cancers de la prostate, du sein et du poumon. <\/p>\n<p>[\/et_pb_text][et_pb_code admin_label=\u00a0\u00bbAdmin &#8211; Do not Remove\u00a0\u00bb module_class=\u00a0\u00bbpostcontent  \u00a0\u00bb _builder_version=\u00a0\u00bb4.21.0&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<div class=\"currentpostcategory\">all<\/div>\n<p>[\/et_pb_code][\/et_pb_column][et_pb_column type=\u00a0\u00bb2_5&Prime; _builder_version=\u00a0\u00bb4.16&Prime; custom_padding=\u00a0\u00bb|||\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb custom_padding__hover=\u00a0\u00bb|||\u00a0\u00bb][et_pb_video src=\u00a0\u00bbhttps:\/\/www.youtube.com\/watch?v=XraTLcnuL-s&#038;t=7s\u00a0\u00bb _builder_version=\u00a0\u00bb4.23.1&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb custom_margin=\u00a0\u00bb4px||||false|false\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][\/et_pb_video][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00a0\u00bb3_5,2_5&Prime; admin_label=\u00a0\u00bbThe Public &#8211; Patient Advisory Board\u00a0\u00bb _builder_version=\u00a0\u00bb4.23.1&Prime; background_size=\u00a0\u00bbinitial\u00a0\u00bb background_position=\u00a0\u00bbtop_left\u00a0\u00bb background_repeat=\u00a0\u00bbrepeat\u00a0\u00bb custom_margin=\u00a0\u00bb||||false|false\u00a0\u00bb custom_margin_tablet=\u00a0\u00bb||60px||false|false\u00a0\u00bb custom_margin_phone=\u00a0\u00bb||60px||false|false\u00a0\u00bb custom_margin_last_edited=\u00a0\u00bbon|tablet\u00a0\u00bb collapsed=\u00a0\u00bbon\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_column type=\u00a0\u00bb3_5&Prime; _builder_version=\u00a0\u00bb4.16&Prime; custom_padding=\u00a0\u00bb|||\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb custom_padding__hover=\u00a0\u00bb|||\u00a0\u00bb][et_pb_text _builder_version=\u00a0\u00bb4.23.1&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb header_3_line_height=\u00a0\u00bb1.1em\u00a0\u00bb header_4_line_height=\u00a0\u00bb1.3em\u00a0\u00bb custom_margin=\u00a0\u00bb0px||||false|false\u00a0\u00bb custom_padding=\u00a0\u00bb0px||||false|false\u00a0\u00bb header_3_line_height_tablet=\u00a0\u00bb1.1em\u00a0\u00bb header_3_line_height_phone=\u00a0\u00bb1.1em\u00a0\u00bb header_3_line_height_last_edited=\u00a0\u00bbon|tablet\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<h3>Le Conseil consultatif du public et des patients<\/h3>\n<p>L\u2019objectif ultime d\u2019OPTIMA est de trouver des options de traitement meilleures et plus personnalis\u00e9es pour les patients et de leur garantir une bonne qualit\u00e9 de vie. \u00c9coutez quatre membres du conseil consultatif public\/patient d\u2019OPTIMA parler de leur implication dans les organisations de d\u00e9fense des patients, de leur parcours contre le cancer et de leurs espoirs pour les futurs patients.<\/p>\n<p>[\/et_pb_text][et_pb_code admin_label=\u00a0\u00bbAdmin &#8211; Do not Remove\u00a0\u00bb module_class=\u00a0\u00bbpostcontent  \u00a0\u00bb _builder_version=\u00a0\u00bb4.21.0&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<div class=\"currentpostcategory\">all<\/div>\n<p>[\/et_pb_code][\/et_pb_column][et_pb_column type=\u00a0\u00bb2_5&Prime; _builder_version=\u00a0\u00bb4.16&Prime; custom_padding=\u00a0\u00bb|||\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb custom_padding__hover=\u00a0\u00bb|||\u00a0\u00bb][et_pb_video src=\u00a0\u00bbhttps:\/\/youtu.be\/G2Q01dvhKqs\u00a0\u00bb _builder_version=\u00a0\u00bb4.22.1&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb custom_margin=\u00a0\u00bb4px||||false|false\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][\/et_pb_video][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00a0\u00bb3_5,2_5&Prime; admin_label=\u00a0\u00bbConchi Biurrun\u00a0\u00bb _builder_version=\u00a0\u00bb4.23.1&Prime; background_size=\u00a0\u00bbinitial\u00a0\u00bb background_position=\u00a0\u00bbtop_left\u00a0\u00bb background_repeat=\u00a0\u00bbrepeat\u00a0\u00bb custom_margin=\u00a0\u00bb||||false|false\u00a0\u00bb custom_margin_tablet=\u00a0\u00bb||60px||false|false\u00a0\u00bb custom_margin_phone=\u00a0\u00bb||60px||false|false\u00a0\u00bb custom_margin_last_edited=\u00a0\u00bbon|tablet\u00a0\u00bb collapsed=\u00a0\u00bbon\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_column type=\u00a0\u00bb3_5&Prime; _builder_version=\u00a0\u00bb4.16&Prime; custom_padding=\u00a0\u00bb|||\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb custom_padding__hover=\u00a0\u00bb|||\u00a0\u00bb][et_pb_text _builder_version=\u00a0\u00bb4.23.1&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb header_3_line_height=\u00a0\u00bb1.1em\u00a0\u00bb header_4_line_height=\u00a0\u00bb1.3em\u00a0\u00bb custom_margin=\u00a0\u00bb0px||||false|false\u00a0\u00bb custom_padding=\u00a0\u00bb0px||||false|false\u00a0\u00bb header_3_line_height_tablet=\u00a0\u00bb1.1em\u00a0\u00bb header_3_line_height_phone=\u00a0\u00bb1.1em\u00a0\u00bb header_3_line_height_last_edited=\u00a0\u00bbon|tablet\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<h3>Conchi Biurrun, Spanish Breast Cancer Federation of Associations<\/h3>\n<p>Conchi Biurrun, de la F\u00e9d\u00e9ration espagnole des associations de lutte contre le cancer du sein et membre du Conseil consultatif public\/patient d\u2019OPTIMA, parle de son parcours en tant que patiente atteinte d\u2019un cancer du sein, de son implication dans le projet OPTIMA et de ses espoirs que ce projet conduise \u00e0 de meilleures options de traitement plus personnalis\u00e9es et \u00e0 une meilleure qualit\u00e9 de vie pour les patientes.[\/et_pb_text][et_pb_code admin_label=\u00a0\u00bbAdmin &#8211; Do not Remove\u00a0\u00bb module_class=\u00a0\u00bbpostcontent  \u00a0\u00bb _builder_version=\u00a0\u00bb4.21.0&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<div class=\"currentpostcategory\">all<\/div>\n<p>[\/et_pb_code][\/et_pb_column][et_pb_column type=\u00a0\u00bb2_5&Prime; _builder_version=\u00a0\u00bb4.16&Prime; custom_padding=\u00a0\u00bb|||\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb custom_padding__hover=\u00a0\u00bb|||\u00a0\u00bb][et_pb_video src=\u00a0\u00bbhttps:\/\/youtu.be\/dbFVoDFDu08&Prime; _builder_version=\u00a0\u00bb4.22.1&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb custom_margin=\u00a0\u00bb4px||||false|false\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][\/et_pb_video][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00a0\u00bb3_5,2_5&Prime; admin_label=\u00a0\u00bbErik Briers\u00a0\u00bb _builder_version=\u00a0\u00bb4.23.1&Prime; background_size=\u00a0\u00bbinitial\u00a0\u00bb background_position=\u00a0\u00bbtop_left\u00a0\u00bb background_repeat=\u00a0\u00bbrepeat\u00a0\u00bb custom_margin=\u00a0\u00bb||||false|false\u00a0\u00bb custom_margin_tablet=\u00a0\u00bb||60px||false|false\u00a0\u00bb custom_margin_phone=\u00a0\u00bb||60px||false|false\u00a0\u00bb custom_margin_last_edited=\u00a0\u00bbon|tablet\u00a0\u00bb collapsed=\u00a0\u00bbon\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_column type=\u00a0\u00bb3_5&Prime; _builder_version=\u00a0\u00bb4.16&Prime; custom_padding=\u00a0\u00bb|||\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb custom_padding__hover=\u00a0\u00bb|||\u00a0\u00bb][et_pb_text _builder_version=\u00a0\u00bb4.23.1&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb header_3_line_height=\u00a0\u00bb1.1em\u00a0\u00bb header_4_line_height=\u00a0\u00bb1.3em\u00a0\u00bb custom_margin=\u00a0\u00bb0px||||false|false\u00a0\u00bb custom_padding=\u00a0\u00bb0px||||false|false\u00a0\u00bb header_3_line_height_tablet=\u00a0\u00bb1.1em\u00a0\u00bb header_3_line_height_phone=\u00a0\u00bb1.1em\u00a0\u00bb header_3_line_height_last_edited=\u00a0\u00bbon|tablet\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<h3>Erik Briers, European Prostate Cancer Coalition<\/h3>\n<p>Erik Briers, de la Coalition europ\u00e9enne contre le cancer de la prostate et membre du conseil consultatif des patients et du public d\u2019OPTIMA, parle de son parcours contre le cancer et de la fa\u00e7on dont un projet tel qu\u2019OPTIMA peut aider d\u2019autres patients \u00e0 recevoir un traitement optimal \u00e0 l\u2019aide de preuves et de directives r\u00e9elles.[\/et_pb_text][et_pb_code admin_label=\u00a0\u00bbAdmin &#8211; Do not Remove\u00a0\u00bb module_class=\u00a0\u00bbpostcontent  \u00a0\u00bb _builder_version=\u00a0\u00bb4.21.0&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<div class=\"currentpostcategory\">all<\/div>\n<p>[\/et_pb_code][\/et_pb_column][et_pb_column type=\u00a0\u00bb2_5&Prime; _builder_version=\u00a0\u00bb4.16&Prime; custom_padding=\u00a0\u00bb|||\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb custom_padding__hover=\u00a0\u00bb|||\u00a0\u00bb][et_pb_video src=\u00a0\u00bbhttps:\/\/youtu.be\/bMP0nqXjP0o\u00a0\u00bb _builder_version=\u00a0\u00bb4.22.1&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb custom_margin=\u00a0\u00bb4px||||false|false\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][\/et_pb_video][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00a0\u00bb3_5,2_5&Prime; admin_label=\u00a0\u00bbSeamus Cotter\u00a0\u00bb _builder_version=\u00a0\u00bb4.23.1&Prime; background_size=\u00a0\u00bbinitial\u00a0\u00bb background_position=\u00a0\u00bbtop_left\u00a0\u00bb background_repeat=\u00a0\u00bbrepeat\u00a0\u00bb custom_margin=\u00a0\u00bb||||false|false\u00a0\u00bb custom_margin_tablet=\u00a0\u00bb||60px||false|false\u00a0\u00bb custom_margin_phone=\u00a0\u00bb||60px||false|false\u00a0\u00bb custom_margin_last_edited=\u00a0\u00bbon|tablet\u00a0\u00bb collapsed=\u00a0\u00bbon\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_column type=\u00a0\u00bb3_5&Prime; _builder_version=\u00a0\u00bb4.16&Prime; custom_padding=\u00a0\u00bb|||\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb custom_padding__hover=\u00a0\u00bb|||\u00a0\u00bb][et_pb_text _builder_version=\u00a0\u00bb4.23.1&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb header_3_line_height=\u00a0\u00bb1.1em\u00a0\u00bb header_4_line_height=\u00a0\u00bb1.3em\u00a0\u00bb custom_margin=\u00a0\u00bb0px||||false|false\u00a0\u00bb custom_padding=\u00a0\u00bb0px||||false|false\u00a0\u00bb header_3_line_height_tablet=\u00a0\u00bb1.1em\u00a0\u00bb header_3_line_height_phone=\u00a0\u00bb1.1em\u00a0\u00bb header_3_line_height_last_edited=\u00a0\u00bbon|tablet\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<h3>Seamus Cotter, Irish Lung Cancer Community<\/h3>\n<p>\u00c9coutez Seamus Cotter, de la communaut\u00e9 irlandaise du cancer du poumon et membre du conseil consultatif des patients et du public d\u2019OPTIMA, parler de son exp\u00e9rience avec les essais cliniques et de l\u2019importance de donner des informations claires sur des traitements sp\u00e9cifiques aux patients pour une d\u00e9cision \u00e9clair\u00e9e.[\/et_pb_text][et_pb_code admin_label=\u00a0\u00bbAdmin &#8211; Do not Remove\u00a0\u00bb module_class=\u00a0\u00bbpostcontent  \u00a0\u00bb _builder_version=\u00a0\u00bb4.21.0&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<div class=\"currentpostcategory\">all<\/div>\n<p>[\/et_pb_code][\/et_pb_column][et_pb_column type=\u00a0\u00bb2_5&Prime; _builder_version=\u00a0\u00bb4.16&Prime; custom_padding=\u00a0\u00bb|||\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb custom_padding__hover=\u00a0\u00bb|||\u00a0\u00bb][et_pb_video src=\u00a0\u00bbhttps:\/\/youtu.be\/48FCpuKDDqM\u00a0\u00bb _builder_version=\u00a0\u00bb4.22.1&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb custom_margin=\u00a0\u00bb4px||||false|false\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][\/et_pb_video][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00a0\u00bb3_5,2_5&Prime; admin_label=\u00a0\u00bbMarjo Forsblom\u00a0\u00bb _builder_version=\u00a0\u00bb4.23.1&Prime; background_size=\u00a0\u00bbinitial\u00a0\u00bb background_position=\u00a0\u00bbtop_left\u00a0\u00bb background_repeat=\u00a0\u00bbrepeat\u00a0\u00bb custom_margin=\u00a0\u00bb||||false|false\u00a0\u00bb custom_margin_tablet=\u00a0\u00bb||60px||false|false\u00a0\u00bb custom_margin_phone=\u00a0\u00bb||60px||false|false\u00a0\u00bb custom_margin_last_edited=\u00a0\u00bbon|tablet\u00a0\u00bb collapsed=\u00a0\u00bbon\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_column type=\u00a0\u00bb3_5&Prime; _builder_version=\u00a0\u00bb4.16&Prime; custom_padding=\u00a0\u00bb|||\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb custom_padding__hover=\u00a0\u00bb|||\u00a0\u00bb][et_pb_text _builder_version=\u00a0\u00bb4.23.1&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb header_3_line_height=\u00a0\u00bb1.1em\u00a0\u00bb header_4_line_height=\u00a0\u00bb1.3em\u00a0\u00bb custom_margin=\u00a0\u00bb0px||||false|false\u00a0\u00bb custom_padding=\u00a0\u00bb0px||||false|false\u00a0\u00bb header_3_line_height_tablet=\u00a0\u00bb1.1em\u00a0\u00bb header_3_line_height_phone=\u00a0\u00bb1.1em\u00a0\u00bb header_3_line_height_last_edited=\u00a0\u00bbon|tablet\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<h3>Marjo Forsblom, Lung Cancer Europe<\/h3>\n<p>Marjo Forsblom de Lung Cancer Europe \u00e9tait membre du conseil consultatif public\/patient d\u2019OPTIMA. Dans cette vid\u00e9o, elle explique comment OPTIMA utilisera les donn\u00e9es de sant\u00e9 \u00e0 bon escient et vise \u00e0 d\u00e9velopper un outil qui sait ce qui est le mieux pour un patient dans une situation sp\u00e9cifique. Malheureusement, elle est d\u00e9c\u00e9d\u00e9e en octobre 2023. Avec la b\u00e9n\u00e9diction de sa famille, nous avons d\u00e9cid\u00e9 de garder sa vid\u00e9o ici. Elle manquera beaucoup \u00e0 ses amis et coll\u00e8gues d\u2019OPTIMA.<\/p>\n<p>[\/et_pb_text][et_pb_code admin_label=\u00a0\u00bbAdmin &#8211; Do not Remove\u00a0\u00bb module_class=\u00a0\u00bbpostcontent  \u00a0\u00bb _builder_version=\u00a0\u00bb4.21.0&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<div class=\"currentpostcategory\">all<\/div>\n<p>[\/et_pb_code][\/et_pb_column][et_pb_column type=\u00a0\u00bb2_5&Prime; _builder_version=\u00a0\u00bb4.16&Prime; custom_padding=\u00a0\u00bb|||\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb custom_padding__hover=\u00a0\u00bb|||\u00a0\u00bb][et_pb_video src=\u00a0\u00bbhttps:\/\/youtu.be\/Iu0Qzt9VMOg\u00a0\u00bb _builder_version=\u00a0\u00bb4.22.1&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb custom_margin=\u00a0\u00bb4px||||false|false\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][\/et_pb_video][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00a0\u00bb3_5,2_5&Prime; admin_label=\u00a0\u00bbNadia Harbeck\u00a0\u00bb _builder_version=\u00a0\u00bb4.23.1&Prime; background_size=\u00a0\u00bbinitial\u00a0\u00bb background_position=\u00a0\u00bbtop_left\u00a0\u00bb background_repeat=\u00a0\u00bbrepeat\u00a0\u00bb custom_margin=\u00a0\u00bb||||false|false\u00a0\u00bb custom_margin_tablet=\u00a0\u00bb||60px||false|false\u00a0\u00bb custom_margin_phone=\u00a0\u00bb||60px||false|false\u00a0\u00bb custom_margin_last_edited=\u00a0\u00bbon|tablet\u00a0\u00bb collapsed=\u00a0\u00bbon\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_column type=\u00a0\u00bb3_5&Prime; _builder_version=\u00a0\u00bb4.16&Prime; custom_padding=\u00a0\u00bb|||\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb custom_padding__hover=\u00a0\u00bb|||\u00a0\u00bb][et_pb_text _builder_version=\u00a0\u00bb4.23.1&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb header_3_line_height=\u00a0\u00bb1.1em\u00a0\u00bb header_4_line_height=\u00a0\u00bb1.3em\u00a0\u00bb custom_margin=\u00a0\u00bb0px||||false|false\u00a0\u00bb custom_padding=\u00a0\u00bb0px||||false|false\u00a0\u00bb header_3_line_height_tablet=\u00a0\u00bb1.1em\u00a0\u00bb header_3_line_height_phone=\u00a0\u00bb1.1em\u00a0\u00bb header_3_line_height_last_edited=\u00a0\u00bbon|tablet\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<h3>Nadia Harbeck, LMU<\/h3>\n<h4>Apprendre \u00e0 partir de donn\u00e9es r\u00e9elles bien prot\u00e9g\u00e9es pour trouver les meilleures th\u00e9rapies<\/h4>\n<p>\u00c9coutez le Dr Nadia Harbeck, directrice du centre du sein de l\u2019h\u00f4pital universitaire LMU \u00e0 Munich, expliquer ce que sont les m\u00e9gadonn\u00e9es, les preuves du monde r\u00e9el et l\u2019intelligence artificielle dans le contexte du traitement et de la recherche sur le cancer du sein dans le cadre du projet OPTIMA.<\/p>\n<p>&nbsp;<\/p>\n<p>[\/et_pb_text][et_pb_code admin_label=\u00a0\u00bbAdmin &#8211; Do not Remove\u00a0\u00bb module_class=\u00a0\u00bbpostcontent  \u00a0\u00bb _builder_version=\u00a0\u00bb4.21.0&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<div class=\"currentpostcategory\">tout<\/div>\n<p>[\/et_pb_code][\/et_pb_column][et_pb_column type=\u00a0\u00bb2_5&Prime; _builder_version=\u00a0\u00bb4.16&Prime; custom_padding=\u00a0\u00bb|||\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb custom_padding__hover=\u00a0\u00bb|||\u00a0\u00bb][et_pb_video src=\u00a0\u00bbhttps:\/\/www.youtube.com\/watch?v=lwW-gR0Cg94&Prime; _builder_version=\u00a0\u00bb4.23.1&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb custom_margin=\u00a0\u00bb4px||||false|false\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][\/et_pb_video][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00a0\u00bb3_5,2_5&Prime; admin_label=\u00a0\u00bbTorsten Blum, Helios\u00a0\u00bb _builder_version=\u00a0\u00bb4.23.1&Prime; background_size=\u00a0\u00bbinitial\u00a0\u00bb background_position=\u00a0\u00bbtop_left\u00a0\u00bb background_repeat=\u00a0\u00bbrepeat\u00a0\u00bb custom_margin=\u00a0\u00bb||||false|false\u00a0\u00bb custom_margin_tablet=\u00a0\u00bb||60px||false|false\u00a0\u00bb custom_margin_phone=\u00a0\u00bb||60px||false|false\u00a0\u00bb custom_margin_last_edited=\u00a0\u00bbon|tablet\u00a0\u00bb collapsed=\u00a0\u00bbon\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_column type=\u00a0\u00bb3_5&Prime; _builder_version=\u00a0\u00bb4.16&Prime; custom_padding=\u00a0\u00bb|||\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb custom_padding__hover=\u00a0\u00bb|||\u00a0\u00bb][et_pb_text _builder_version=\u00a0\u00bb4.23.1&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb header_3_line_height=\u00a0\u00bb1.1em\u00a0\u00bb header_4_line_height=\u00a0\u00bb1.3em\u00a0\u00bb custom_margin=\u00a0\u00bb0px||||false|false\u00a0\u00bb custom_padding=\u00a0\u00bb0px||||false|false\u00a0\u00bb header_3_line_height_tablet=\u00a0\u00bb1.1em\u00a0\u00bb header_3_line_height_phone=\u00a0\u00bb1.1em\u00a0\u00bb header_3_line_height_last_edited=\u00a0\u00bbon|tablet\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<h3>Torsten Blum, H\u00e9lios<\/h3>\n<h4>L\u2019importance de partager les donn\u00e9es cliniques pour une plate-forme OPTIMA des plus pr\u00e9cieuses &#8211; Torsten Blum<\/h4>\n<p>Le Dr Torsten Gerriet Blum, m\u00e9decin-chef et pneumologue \u00e0 la clinique Helios, explique l\u2019importance du partage des donn\u00e9es, du big data, des preuves du monde r\u00e9el et de l\u2019intelligence artificielle dans le contexte du traitement et de la recherche sur le cancer du poumon dans le cadre du projet OPTIMA.<\/p>\n<p>&nbsp;<\/p>\n<p>[\/et_pb_text][et_pb_code admin_label=\u00a0\u00bbAdmin &#8211; Do not Remove\u00a0\u00bb module_class=\u00a0\u00bbpostcontent  \u00a0\u00bb _builder_version=\u00a0\u00bb4.21.0&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<div class=\"currentpostcategory\">all<\/div>\n<p>[\/et_pb_code][\/et_pb_column][et_pb_column type=\u00a0\u00bb2_5&Prime; _builder_version=\u00a0\u00bb4.16&Prime; custom_padding=\u00a0\u00bb|||\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb custom_padding__hover=\u00a0\u00bb|||\u00a0\u00bb][et_pb_video src=\u00a0\u00bbhttps:\/\/www.youtube.com\/watch?v=QSLjx8pAEfA\u00a0\u00bb _builder_version=\u00a0\u00bb4.23.1&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb custom_margin=\u00a0\u00bb4px||||false|false\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][\/et_pb_video][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00a0\u00bb3_5,2_5&Prime; admin_label=\u00a0\u00bbMichael Bussmann, Helmholtz\u00a0\u00bb _builder_version=\u00a0\u00bb4.23.1&Prime; background_size=\u00a0\u00bbinitial\u00a0\u00bb background_position=\u00a0\u00bbtop_left\u00a0\u00bb background_repeat=\u00a0\u00bbrepeat\u00a0\u00bb custom_margin=\u00a0\u00bb||||false|false\u00a0\u00bb custom_margin_tablet=\u00a0\u00bb||60px||false|false\u00a0\u00bb custom_margin_phone=\u00a0\u00bb||60px||false|false\u00a0\u00bb custom_margin_last_edited=\u00a0\u00bbon|tablet\u00a0\u00bb collapsed=\u00a0\u00bbon\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_column type=\u00a0\u00bb3_5&Prime; _builder_version=\u00a0\u00bb4.16&Prime; custom_padding=\u00a0\u00bb|||\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb custom_padding__hover=\u00a0\u00bb|||\u00a0\u00bb][et_pb_text _builder_version=\u00a0\u00bb4.23.1&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb header_3_line_height=\u00a0\u00bb1.1em\u00a0\u00bb header_4_line_height=\u00a0\u00bb1.3em\u00a0\u00bb custom_margin=\u00a0\u00bb0px||||false|false\u00a0\u00bb custom_padding=\u00a0\u00bb0px||||false|false\u00a0\u00bb header_3_line_height_tablet=\u00a0\u00bb1.1em\u00a0\u00bb header_3_line_height_phone=\u00a0\u00bb1.1em\u00a0\u00bb header_3_line_height_last_edited=\u00a0\u00bbon|tablet\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<h3>Michael Bussmann, Helmholtz<\/h3>\n<h4>Utiliser l\u2019intelligence artificielle pour transformer les donn\u00e9es en connaissances<\/h4>\n<p>Le Dr Michael Bussmann, directeur fondateur du CASUS (Center for Advanced Systems Understanding) dirige le groupe de travail sur la mise en \u0153uvre de la base de connaissances sur l\u2019intelligence artificielle au sein d\u2019OPTIMA. Dans cette vid\u00e9o, apprenez-en plus sur la fa\u00e7on dont l\u2019intelligence artificielle peut apporter une valeur ajout\u00e9e aux soins en oncologie dans le cadre du projet OPTIMA.<\/p>\n<p>&nbsp;<\/p>\n<p>[\/et_pb_text][et_pb_code admin_label=\u00a0\u00bbAdmin &#8211; Do not Remove\u00a0\u00bb module_class=\u00a0\u00bbpostcontent  \u00a0\u00bb _builder_version=\u00a0\u00bb4.21.0&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<div class=\"currentpostcategory\">tout<\/div>\n<p>[\/et_pb_code][\/et_pb_column][et_pb_column type=\u00a0\u00bb2_5&Prime; _builder_version=\u00a0\u00bb4.16&Prime; custom_padding=\u00a0\u00bb|||\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb custom_padding__hover=\u00a0\u00bb|||\u00a0\u00bb][et_pb_video src=\u00a0\u00bbhttps:\/\/www.youtube.com\/watch?v=wPSYXv8pyRA\u00a0\u00bb _builder_version=\u00a0\u00bb4.23.1&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb custom_margin=\u00a0\u00bb4px||||false|false\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][\/et_pb_video][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00a0\u00bb3_5,2_5&Prime; admin_label=\u00a0\u00bbNicolas Mottet, EAU\u00a0\u00bb _builder_version=\u00a0\u00bb4.23.1&Prime; background_size=\u00a0\u00bbinitial\u00a0\u00bb background_position=\u00a0\u00bbtop_left\u00a0\u00bb background_repeat=\u00a0\u00bbrepeat\u00a0\u00bb custom_margin=\u00a0\u00bb||||false|false\u00a0\u00bb custom_margin_tablet=\u00a0\u00bb||60px||false|false\u00a0\u00bb custom_margin_phone=\u00a0\u00bb||60px||false|false\u00a0\u00bb custom_margin_last_edited=\u00a0\u00bbon|tablet\u00a0\u00bb collapsed=\u00a0\u00bbon\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_column type=\u00a0\u00bb3_5&Prime; _builder_version=\u00a0\u00bb4.16&Prime; custom_padding=\u00a0\u00bb|||\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb custom_padding__hover=\u00a0\u00bb|||\u00a0\u00bb][et_pb_text _builder_version=\u00a0\u00bb4.23.1&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb header_3_line_height=\u00a0\u00bb1.1em\u00a0\u00bb header_4_line_height=\u00a0\u00bb1.3em\u00a0\u00bb custom_margin=\u00a0\u00bb0px||||false|false\u00a0\u00bb custom_padding=\u00a0\u00bb0px||||false|false\u00a0\u00bb header_3_line_height_tablet=\u00a0\u00bb1.1em\u00a0\u00bb header_3_line_height_phone=\u00a0\u00bb1.1em\u00a0\u00bb header_3_line_height_last_edited=\u00a0\u00bbon|tablet\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<h3>Nicolas Mottet, Association europ\u00e9enne d&rsquo;urologie<\/h3>\n<h4>Am\u00e9liorer les lignes directrices gr\u00e2ce \u00e0 des donn\u00e9es du monde r\u00e9el pour un meilleur traitement<\/h4>\n<p>Le Pr Nicolas Mottet est chef du service d\u2019urologie du Centre Hospitalier Universitaire de Saint-Etienne, et impliqu\u00e9 en tant que Pr\u00e9sident de l\u2019Association europ\u00e9enne d&rsquo;urologie. Il explique comment am\u00e9liorer les lignes directrices \u00e0 l\u2019aide de donn\u00e9es r\u00e9elles pour un meilleur traitement dans le contexte du traitement et de la recherche sur le cancer de la prostate dans le cadre du projet OPTIMA.<\/p>\n<p>&nbsp;<\/p>\n<p>[\/et_pb_text][et_pb_code admin_label=\u00a0\u00bbAdmin &#8211; Do not Remove\u00a0\u00bb module_class=\u00a0\u00bbpostcontent  \u00a0\u00bb _builder_version=\u00a0\u00bb4.21.0&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<div class=\"currentpostcategory\">all<\/div>\n<p>[\/et_pb_code][\/et_pb_column][et_pb_column type=\u00a0\u00bb2_5&Prime; _builder_version=\u00a0\u00bb4.16&Prime; custom_padding=\u00a0\u00bb|||\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb custom_padding__hover=\u00a0\u00bb|||\u00a0\u00bb][et_pb_video src=\u00a0\u00bbhttps:\/\/www.youtube.com\/watch?v=xOy7oCTKxs8&Prime; _builder_version=\u00a0\u00bb4.23.1&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb custom_margin=\u00a0\u00bb4px||||false|false\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][\/et_pb_video][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00a0\u00bb3_5,2_5&Prime; admin_label=\u00a0\u00bbAndreas Kremer &#038; Bertrand De Meulder\u00a0\u00bb _builder_version=\u00a0\u00bb4.23.1&Prime; background_size=\u00a0\u00bbinitial\u00a0\u00bb background_position=\u00a0\u00bbtop_left\u00a0\u00bb background_repeat=\u00a0\u00bbrepeat\u00a0\u00bb custom_margin=\u00a0\u00bb||||false|false\u00a0\u00bb custom_margin_tablet=\u00a0\u00bb||60px||false|false\u00a0\u00bb custom_margin_phone=\u00a0\u00bb||60px||false|false\u00a0\u00bb custom_margin_last_edited=\u00a0\u00bbon|tablet\u00a0\u00bb collapsed=\u00a0\u00bbon\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_column type=\u00a0\u00bb3_5&Prime; _builder_version=\u00a0\u00bb4.16&Prime; custom_padding=\u00a0\u00bb|||\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb custom_padding__hover=\u00a0\u00bb|||\u00a0\u00bb][et_pb_text _builder_version=\u00a0\u00bb4.23.1&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb header_3_line_height=\u00a0\u00bb1.1em\u00a0\u00bb header_4_line_height=\u00a0\u00bb1.3em\u00a0\u00bb custom_margin=\u00a0\u00bb0px||||false|false\u00a0\u00bb custom_padding=\u00a0\u00bb0px||||false|false\u00a0\u00bb header_3_line_height_tablet=\u00a0\u00bb1.1em\u00a0\u00bb header_3_line_height_phone=\u00a0\u00bb1.1em\u00a0\u00bb header_3_line_height_last_edited=\u00a0\u00bbon|tablet\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<h3>Andreas Kremer et Bertrand De Meulder<\/h3>\n<h4>Rendre la plateforme OPTIMA plus utile pour toutes les parties prenantes<\/h4>\n<p>Dr. Andreas Kremer et Dr. Bertrand De Meulder dirigent les t\u00e2ches d\u2019analyse des exigences de la plate-forme ainsi que la mise en \u0153uvre et l\u2019\u00e9valuation de la plate-forme. Dans cette vid\u00e9o, vous pouvez en apprendre davantage sur la plateforme OPTIMA et sur le r\u00f4le de l\u2019intelligence artificielle dans le contexte de la sant\u00e9 dans le cadre du projet OPTIMA.<\/p>\n<p>&nbsp;<\/p>\n<p>[\/et_pb_text][et_pb_code admin_label=\u00a0\u00bbAdmin &#8211; Do not Remove\u00a0\u00bb module_class=\u00a0\u00bbpostcontent  \u00a0\u00bb _builder_version=\u00a0\u00bb4.21.0&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<div class=\"currentpostcategory\">tout<\/div>\n<p>[\/et_pb_code][\/et_pb_column][et_pb_column type=\u00a0\u00bb2_5&Prime; _builder_version=\u00a0\u00bb4.16&Prime; custom_padding=\u00a0\u00bb|||\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb custom_padding__hover=\u00a0\u00bb|||\u00a0\u00bb][et_pb_video src=\u00a0\u00bbhttps:\/\/www.youtube.com\/watch?v=Tnp2CK6_Vvc\u00a0\u00bb _builder_version=\u00a0\u00bb4.23.1&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb custom_margin=\u00a0\u00bb4px||||false|false\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][\/et_pb_video][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00a0\u00bb3_5,2_5&Prime; admin_label=\u00a0\u00bbDr. Pippa Powell\u00a0\u00bb _builder_version=\u00a0\u00bb4.23.1&Prime; background_size=\u00a0\u00bbinitial\u00a0\u00bb background_position=\u00a0\u00bbtop_left\u00a0\u00bb background_repeat=\u00a0\u00bbrepeat\u00a0\u00bb custom_margin=\u00a0\u00bb||||false|false\u00a0\u00bb custom_margin_tablet=\u00a0\u00bb||60px||false|false\u00a0\u00bb custom_margin_phone=\u00a0\u00bb||60px||false|false\u00a0\u00bb custom_margin_last_edited=\u00a0\u00bbon|tablet\u00a0\u00bb collapsed=\u00a0\u00bbon\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_column type=\u00a0\u00bb3_5&Prime; _builder_version=\u00a0\u00bb4.16&Prime; custom_padding=\u00a0\u00bb|||\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb custom_padding__hover=\u00a0\u00bb|||\u00a0\u00bb][et_pb_text _builder_version=\u00a0\u00bb4.23.1&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb header_3_line_height=\u00a0\u00bb1.1em\u00a0\u00bb header_4_line_height=\u00a0\u00bb1.3em\u00a0\u00bb custom_margin=\u00a0\u00bb0px||||false|false\u00a0\u00bb custom_padding=\u00a0\u00bb0px||||false|false\u00a0\u00bb header_3_line_height_tablet=\u00a0\u00bb1.1em\u00a0\u00bb header_3_line_height_phone=\u00a0\u00bb1.1em\u00a0\u00bb header_3_line_height_last_edited=\u00a0\u00bbon|tablet\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<h3>Dr Pippa Powell<\/h3>\n<h4>L\u2019implication du Conseil Consultatif des Patients et du Public d\u2019OPTIMA<\/h4>\n<p>Le Dr Pippa Powell, directrice de la Fondation pulmonaire europ\u00e9enne, cr\u00e9e le lien entre les patients et les organisations de patients, et la recherche souligne dans cette vid\u00e9o l\u2019importance de la participation des patients au projet OPTIMA.<\/p>\n<p>&nbsp;<\/p>\n<p>[\/et_pb_text][et_pb_code admin_label=\u00a0\u00bbAdmin &#8211; Do not Remove\u00a0\u00bb module_class=\u00a0\u00bbpostcontent  \u00a0\u00bb _builder_version=\u00a0\u00bb4.21.0&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<div class=\"currentpostcategory\">tout<\/div>\n<p>[\/et_pb_code][\/et_pb_column][et_pb_column type=\u00a0\u00bb2_5&Prime; _builder_version=\u00a0\u00bb4.16&Prime; custom_padding=\u00a0\u00bb|||\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb custom_padding__hover=\u00a0\u00bb|||\u00a0\u00bb][et_pb_video src=\u00a0\u00bbhttps:\/\/www.youtube.com\/watch?v=wz6A0KakFWk\u00a0\u00bb _builder_version=\u00a0\u00bb4.23.1&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb custom_margin=\u00a0\u00bb4px||||false|false\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][\/et_pb_video][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00a0\u00bb3_5,2_5&Prime; admin_label=\u00a0\u00bbPeter-Paul Willemse\u00a0\u00bb _builder_version=\u00a0\u00bb4.23.1&Prime; background_size=\u00a0\u00bbinitial\u00a0\u00bb background_position=\u00a0\u00bbtop_left\u00a0\u00bb background_repeat=\u00a0\u00bbrepeat\u00a0\u00bb custom_margin=\u00a0\u00bb||||false|false\u00a0\u00bb custom_margin_tablet=\u00a0\u00bb||60px||false|false\u00a0\u00bb custom_margin_phone=\u00a0\u00bb||60px||false|false\u00a0\u00bb custom_margin_last_edited=\u00a0\u00bbon|tablet\u00a0\u00bb collapsed=\u00a0\u00bbon\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_column type=\u00a0\u00bb3_5&Prime; _builder_version=\u00a0\u00bb4.16&Prime; custom_padding=\u00a0\u00bb|||\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb custom_padding__hover=\u00a0\u00bb|||\u00a0\u00bb][et_pb_text _builder_version=\u00a0\u00bb4.23.1&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb header_3_line_height=\u00a0\u00bb1.1em\u00a0\u00bb header_4_line_height=\u00a0\u00bb1.3em\u00a0\u00bb custom_margin=\u00a0\u00bb0px||||false|false\u00a0\u00bb custom_padding=\u00a0\u00bb0px||||false|false\u00a0\u00bb header_3_line_height_tablet=\u00a0\u00bb1.1em\u00a0\u00bb header_3_line_height_phone=\u00a0\u00bb1.1em\u00a0\u00bb header_3_line_height_last_edited=\u00a0\u00bbon|tablet\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<h3>Peter-Paul Willemse, OPTIMA<\/h3>\n<h4>Partager des m\u00e9gadonn\u00e9es et des donn\u00e9es probantes du monde r\u00e9el pour r\u00e9soudre des questions cliniques<\/h4>\n<p>Le Dr Peter-Paul Willemse est professeur adjoint et m\u00e9decin au d\u00e9partement d\u2019oncologie urologique du Centre m\u00e9dical at universitaire d&rsquo;Utrecht. Au sein d\u2019OPTIMA, il repr\u00e9sente la communaut\u00e9 clinique qui traite les patients atteints d\u2019un cancer de la prostate et explique comment le partage de donn\u00e9es massives et de donn\u00e9es probantes du monde r\u00e9el peut aider \u00e0 r\u00e9soudre des questions cliniques dans le cadre du projet OPTIMA.<\/p>\n<p>&nbsp;<\/p>\n<p>[\/et_pb_text][et_pb_code admin_label=\u00a0\u00bbAdmin &#8211; Do not Remove\u00a0\u00bb module_class=\u00a0\u00bbpostcontent  \u00a0\u00bb _builder_version=\u00a0\u00bb4.21.0&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<div class=\"currentpostcategory\">all<\/div>\n<p>[\/et_pb_code][\/et_pb_column][et_pb_column type=\u00a0\u00bb2_5&Prime; _builder_version=\u00a0\u00bb4.16&Prime; custom_padding=\u00a0\u00bb|||\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb custom_padding__hover=\u00a0\u00bb|||\u00a0\u00bb][et_pb_video src=\u00a0\u00bbhttps:\/\/www.youtube.com\/watch?v=yaqJsdpLDP0&Prime; _builder_version=\u00a0\u00bb4.23.1&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb custom_margin=\u00a0\u00bb4px||||false|false\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][\/et_pb_video][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00a0\u00bb3_5,2_5&Prime; admin_label=\u00a0\u00bbProf. Daniel Prieto Alhambra\u00a0\u00bb _builder_version=\u00a0\u00bb4.23.1&Prime; background_size=\u00a0\u00bbinitial\u00a0\u00bb background_position=\u00a0\u00bbtop_left\u00a0\u00bb background_repeat=\u00a0\u00bbrepeat\u00a0\u00bb custom_margin=\u00a0\u00bb||||false|false\u00a0\u00bb custom_margin_tablet=\u00a0\u00bb||60px||false|false\u00a0\u00bb custom_margin_phone=\u00a0\u00bb||60px||false|false\u00a0\u00bb custom_margin_last_edited=\u00a0\u00bbon|tablet\u00a0\u00bb collapsed=\u00a0\u00bbon\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_column type=\u00a0\u00bb3_5&Prime; _builder_version=\u00a0\u00bb4.16&Prime; custom_padding=\u00a0\u00bb|||\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb custom_padding__hover=\u00a0\u00bb|||\u00a0\u00bb][et_pb_text _builder_version=\u00a0\u00bb4.23.1&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb header_3_line_height=\u00a0\u00bb1.1em\u00a0\u00bb header_4_line_height=\u00a0\u00bb1.3em\u00a0\u00bb custom_margin=\u00a0\u00bb0px||||false|false\u00a0\u00bb custom_padding=\u00a0\u00bb0px||||false|false\u00a0\u00bb header_3_line_height_tablet=\u00a0\u00bb1.1em\u00a0\u00bb header_3_line_height_phone=\u00a0\u00bb1.1em\u00a0\u00bb header_3_line_height_last_edited=\u00a0\u00bbon|tablet\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<h3>Prof. Daniel Prieto Alhambra<\/h3>\n<h4>Le Big Data dans le contexte de la sant\u00e9<\/h4>\n<p>Daniel Prieto Alhambra est professeur de pharmaco-\u00e9pidemiologie et il dirige le groupe de travail sur les donn\u00e9es d\u2019\u00e9tudes (non) interventionnelles et la collecte de donn\u00e9es en situation r\u00e9elle au sein d\u2019OPTIMA. Dans cette vid\u00e9o, il aborde le r\u00f4le du big data dans le contexte de la sant\u00e9 dans le cadre du projet OPTIMA.<\/p>\n<p>&nbsp;<\/p>\n<p>[\/et_pb_text][et_pb_code admin_label=\u00a0\u00bbAdmin &#8211; Do not Remove\u00a0\u00bb module_class=\u00a0\u00bbpostcontent  \u00a0\u00bb _builder_version=\u00a0\u00bb4.21.0&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<div class=\"currentpostcategory\">tout<\/div>\n<p>[\/et_pb_code][\/et_pb_column][et_pb_column type=\u00a0\u00bb2_5&Prime; _builder_version=\u00a0\u00bb4.16&Prime; custom_padding=\u00a0\u00bb|||\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb custom_padding__hover=\u00a0\u00bb|||\u00a0\u00bb][et_pb_video src=\u00a0\u00bbhttps:\/\/www.youtube.com\/watch?v=qf-hG2E0fBM\u00a0\u00bb _builder_version=\u00a0\u00bb4.23.1&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb custom_margin=\u00a0\u00bb4px||||false|false\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][\/et_pb_video][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00a0\u00bb3_5,2_5&Prime; admin_label=\u00a0\u00bbM. Roobol\u00a0\u00bb _builder_version=\u00a0\u00bb4.23.1&Prime; background_size=\u00a0\u00bbinitial\u00a0\u00bb background_position=\u00a0\u00bbtop_left\u00a0\u00bb background_repeat=\u00a0\u00bbrepeat\u00a0\u00bb custom_margin=\u00a0\u00bb||||false|false\u00a0\u00bb custom_margin_tablet=\u00a0\u00bb||60px||false|false\u00a0\u00bb custom_margin_phone=\u00a0\u00bb||60px||false|false\u00a0\u00bb custom_margin_last_edited=\u00a0\u00bbon|tablet\u00a0\u00bb collapsed=\u00a0\u00bbon\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_column type=\u00a0\u00bb3_5&Prime; _builder_version=\u00a0\u00bb4.16&Prime; custom_padding=\u00a0\u00bb|||\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb custom_padding__hover=\u00a0\u00bb|||\u00a0\u00bb][et_pb_text _builder_version=\u00a0\u00bb4.23.1&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb header_3_line_height=\u00a0\u00bb1.1em\u00a0\u00bb header_4_line_height=\u00a0\u00bb1.3em\u00a0\u00bb custom_margin=\u00a0\u00bb0px||||false|false\u00a0\u00bb custom_padding=\u00a0\u00bb0px||||false|false\u00a0\u00bb header_3_line_height_tablet=\u00a0\u00bb1.1em\u00a0\u00bb header_3_line_height_phone=\u00a0\u00bb1.1em\u00a0\u00bb header_3_line_height_last_edited=\u00a0\u00bbon|tablet\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<h3>Monique Roobol<\/h3>\n<h4>Transformer les lignes directrices en outils \u00e9lectroniques d\u2019aide \u00e0 la d\u00e9cision pour chaque patient<\/h4>\n<p>Monique Roobol est professeure de prise de d\u00e9cision en urologie et explique ici le projet OPTIMA et pourquoi il est important que le projet traduise les directives cliniques en outils \u00e9lectroniques d\u2019aide \u00e0 la d\u00e9cision.<\/p>\n<p>&nbsp;<\/p>\n<p>[\/et_pb_text][et_pb_code admin_label=\u00a0\u00bbAdmin &#8211; Do not Remove\u00a0\u00bb module_class=\u00a0\u00bbpostcontent  \u00a0\u00bb _builder_version=\u00a0\u00bb4.21.0&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<div class=\"currentpostcategory\">all<\/div>\n<p>[\/et_pb_code][\/et_pb_column][et_pb_column type=\u00a0\u00bb2_5&Prime; _builder_version=\u00a0\u00bb4.16&Prime; custom_padding=\u00a0\u00bb|||\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb custom_padding__hover=\u00a0\u00bb|||\u00a0\u00bb][et_pb_video src=\u00a0\u00bbhttps:\/\/www.youtube.com\/watch?v=bwrO8GOUfdg\u00a0\u00bb _builder_version=\u00a0\u00bb4.23.1&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb custom_margin=\u00a0\u00bb4px||||false|false\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][\/et_pb_video][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00a0\u00bb3_5,2_5&Prime; admin_label=\u00a0\u00bbJames N&rsquo;Dow and Hagen Kr\u00fcger\u00a0\u00bb _builder_version=\u00a0\u00bb4.23.1&Prime; background_size=\u00a0\u00bbinitial\u00a0\u00bb background_position=\u00a0\u00bbtop_left\u00a0\u00bb background_repeat=\u00a0\u00bbrepeat\u00a0\u00bb custom_margin=\u00a0\u00bb||||false|false\u00a0\u00bb custom_margin_tablet=\u00a0\u00bb||60px||false|false\u00a0\u00bb custom_margin_phone=\u00a0\u00bb||60px||false|false\u00a0\u00bb custom_margin_last_edited=\u00a0\u00bbon|tablet\u00a0\u00bb collapsed=\u00a0\u00bboff\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_column type=\u00a0\u00bb3_5&Prime; _builder_version=\u00a0\u00bb4.16&Prime; custom_padding=\u00a0\u00bb|||\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb custom_padding__hover=\u00a0\u00bb|||\u00a0\u00bb][et_pb_text _builder_version=\u00a0\u00bb4.23.1&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb header_3_line_height=\u00a0\u00bb1.1em\u00a0\u00bb header_4_line_height=\u00a0\u00bb1.3em\u00a0\u00bb custom_margin=\u00a0\u00bb0px||||false|false\u00a0\u00bb custom_padding=\u00a0\u00bb0px||||false|false\u00a0\u00bb header_3_line_height_tablet=\u00a0\u00bb1.1em\u00a0\u00bb header_3_line_height_phone=\u00a0\u00bb1.1em\u00a0\u00bb header_3_line_height_last_edited=\u00a0\u00bbon|tablet\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<h3>James N\u2019Dow et Hagen Kr\u00fcger<\/h3>\n<h4>Unir nos forces dans le cadre d\u2019un partenariat public-priv\u00e9 pour trouver de meilleurs traitements pour les patients atteints de cancer<\/h4>\n<p>Prof. Dr. James N\u2019Dow, coordinateur acad\u00e9mique et secr\u00e9taire g\u00e9n\u00e9ral adjoint de l\u2019Association europ\u00e9enne d&rsquo;urologie et Dr. Hagen Kr\u00fcger, directeur m\u00e9dical principal chez Pfizer, coordonnent ensemble le projet OPTIMA. Ici, ils donnent un aper\u00e7u du projet et parlent de l\u2019importance de la collaboration entre les partenaires publics et priv\u00e9s dans le cadre de l\u2019initiative IMI (pour Innovative Medicines Initiatives).<\/p>\n<p>&nbsp;<\/p>\n<p>[\/et_pb_text][et_pb_code admin_label=\u00a0\u00bbAdmin &#8211; Do not Remove\u00a0\u00bb module_class=\u00a0\u00bbpostcontent  \u00a0\u00bb _builder_version=\u00a0\u00bb4.21.0&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<div class=\"currentpostcategory\">all<\/div>\n<p>[\/et_pb_code][\/et_pb_column][et_pb_column type=\u00a0\u00bb2_5&Prime; _builder_version=\u00a0\u00bb4.16&Prime; custom_padding=\u00a0\u00bb|||\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb custom_padding__hover=\u00a0\u00bb|||\u00a0\u00bb][et_pb_video src=\u00a0\u00bbhttps:\/\/www.youtube.com\/watch?v=6dPnsVgTvkM\u00a0\u00bb _builder_version=\u00a0\u00bb4.23.1&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb custom_margin=\u00a0\u00bb4px||||false|false\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][\/et_pb_video][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00a0\u00bb3_5,2_5&Prime; admin_label=\u00a0\u00bbAspects juridiques et \u00e9thiques\u00a0\u00bb _builder_version=\u00a0\u00bb4.23.1&Prime; background_size=\u00a0\u00bbinitial\u00a0\u00bb background_position=\u00a0\u00bbtop_left\u00a0\u00bb background_repeat=\u00a0\u00bbrepeat\u00a0\u00bb custom_margin=\u00a0\u00bb||||false|false\u00a0\u00bb custom_margin_tablet=\u00a0\u00bb||60px||false|false\u00a0\u00bb custom_margin_phone=\u00a0\u00bb||60px||false|false\u00a0\u00bb custom_margin_last_edited=\u00a0\u00bbon|tablet\u00a0\u00bb collapsed=\u00a0\u00bbon\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_column type=\u00a0\u00bb3_5&Prime; _builder_version=\u00a0\u00bb4.16&Prime; custom_padding=\u00a0\u00bb|||\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb custom_padding__hover=\u00a0\u00bb|||\u00a0\u00bb][et_pb_text _builder_version=\u00a0\u00bb4.24.3&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb header_2_line_height=\u00a0\u00bb1.3em\u00a0\u00bb header_3_line_height=\u00a0\u00bb1.1em\u00a0\u00bb header_4_line_height=\u00a0\u00bb1.3em\u00a0\u00bb custom_margin=\u00a0\u00bb0px||||false|false\u00a0\u00bb custom_padding=\u00a0\u00bb0px||||false|false\u00a0\u00bb header_3_line_height_tablet=\u00a0\u00bb1.1em\u00a0\u00bb header_3_line_height_phone=\u00a0\u00bb1.1em\u00a0\u00bb header_3_line_height_last_edited=\u00a0\u00bbon|tablet\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<h2>Les aspects juridiques et \u00e9thiques fascinants d\u2019OPTIMA<\/h2>\n<p>Curieux de conna\u00eetre les aspects juridiques et \u00e9thiques d\u2019OPTIMA ? Nous pr\u00e9sentons notre Work Package 2, qui porte sur la recherche sur la protection des donn\u00e9es et le cadre juridique \u00e9mergent autour de l\u2019IA et sur la garantie du respect des normes \u00e9thiques et juridiques au niveau de l\u2019UE. \u202fApprenez-en plus sur les aspects juridiques fascinants d\u2019OPTIMA dans la s\u00e9rie de courtes vid\u00e9os suivantes.  <\/p>\n<p>&nbsp;<\/p>\n<p>[\/et_pb_text][et_pb_code admin_label=\u00a0\u00bbAdmin &#8211; Ne pas supprimer\u00a0\u00bb module_class=\u00a0\u00bbpostcontent  \u00a0\u00bb _builder_version=\u00a0\u00bb4.21.0&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<div class=\"currentpostcategory\">tout<\/div>\n<p>[\/et_pb_code][\/et_pb_column][et_pb_column type=\u00a0\u00bb2_5&Prime; _builder_version=\u00a0\u00bb4.16&Prime; custom_padding=\u00a0\u00bb|||\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb custom_padding__hover=\u00a0\u00bb|||\u00a0\u00bb][et_pb_video src=\u00a0\u00bbhttps:\/\/youtu.be\/lmW0C8Z5nDE\u00a0\u00bb _builder_version=\u00a0\u00bb4.24.3&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb custom_margin=\u00a0\u00bb4px||||false|false\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][\/et_pb_video][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00a0\u00bb3_5,2_5&Prime; admin_label=\u00a0\u00bbDonn\u00e9es personnelles et non personnelles\u00a0\u00bb _builder_version=\u00a0\u00bb4.23.1&Prime; background_size=\u00a0\u00bbinitial\u00a0\u00bb background_position=\u00a0\u00bbtop_left\u00a0\u00bb background_repeat=\u00a0\u00bbrepeat\u00a0\u00bb custom_margin=\u00a0\u00bb||||false|false\u00a0\u00bb custom_margin_tablet=\u00a0\u00bb||60px||false|false\u00a0\u00bb custom_margin_phone=\u00a0\u00bb||60px||false|false\u00a0\u00bb custom_margin_last_edited=\u00a0\u00bbon|tablet\u00a0\u00bb collapsed=\u00a0\u00bbon\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_column type=\u00a0\u00bb3_5&Prime; _builder_version=\u00a0\u00bb4.16&Prime; custom_padding=\u00a0\u00bb|||\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb custom_padding__hover=\u00a0\u00bb|||\u00a0\u00bb][et_pb_text _builder_version=\u00a0\u00bb4.24.3&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb header_2_line_height=\u00a0\u00bb1.3em\u00a0\u00bb header_3_line_height=\u00a0\u00bb1.1em\u00a0\u00bb header_4_line_height=\u00a0\u00bb1.3em\u00a0\u00bb custom_margin=\u00a0\u00bb0px||||false|false\u00a0\u00bb custom_padding=\u00a0\u00bb0px||||false|false\u00a0\u00bb header_3_line_height_tablet=\u00a0\u00bb1.1em\u00a0\u00bb header_3_line_height_phone=\u00a0\u00bb1.1em\u00a0\u00bb header_3_line_height_last_edited=\u00a0\u00bbon|tablet\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<h2>Diff\u00e9rence entre les donn\u00e9es personnelles et les donn\u00e9es non personnelles  <\/h2>\n<p>La vid\u00e9o explique la diff\u00e9rence entre les donn\u00e9es personnelles et non personnelles, car cette distinction a une influence sur la classification juridique, par exemple l\u2019application du RGPD. OPTIMA utilise des donn\u00e9es personnelles et d\u00e9personnalis\u00e9es. Qu\u2019est-ce que cela signifie ? Pour en savoir plus, regardez notre vid\u00e9o.   <\/p>\n<p>[\/et_pb_text][et_pb_code admin_label=\u00a0\u00bbAdmin &#8211; Ne pas supprimer\u00a0\u00bb module_class=\u00a0\u00bbpostcontent  \u00a0\u00bb _builder_version=\u00a0\u00bb4.21.0&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<div class=\"currentpostcategory\">tout<\/div>\n<p>[\/et_pb_code][\/et_pb_column][et_pb_column type=\u00a0\u00bb2_5&Prime; _builder_version=\u00a0\u00bb4.16&Prime; custom_padding=\u00a0\u00bb|||\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb custom_padding__hover=\u00a0\u00bb|||\u00a0\u00bb][et_pb_video src=\u00a0\u00bbhttps:\/\/youtu.be\/c9S74j9dwHA\u00a0\u00bb _builder_version=\u00a0\u00bb4.24.3&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb custom_margin=\u00a0\u00bb4px||||false|false\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][\/et_pb_video][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00a0\u00bb3_5,2_5&Prime; admin_label=\u00a0\u00bbDonn\u00e9es synth\u00e9tiques\u00a0\u00bb _builder_version=\u00a0\u00bb4.23.1&Prime; background_size=\u00a0\u00bbinitial\u00a0\u00bb background_position=\u00a0\u00bbtop_left\u00a0\u00bb background_repeat=\u00a0\u00bbrepeat\u00a0\u00bb custom_margin=\u00a0\u00bb||||false|false\u00a0\u00bb custom_margin_tablet=\u00a0\u00bb||60px||false|false\u00a0\u00bb custom_margin_phone=\u00a0\u00bb||60px||false|false\u00a0\u00bb custom_margin_last_edited=\u00a0\u00bbon|tablet\u00a0\u00bb collapsed=\u00a0\u00bbon\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_column type=\u00a0\u00bb3_5&Prime; _builder_version=\u00a0\u00bb4.16&Prime; custom_padding=\u00a0\u00bb|||\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb custom_padding__hover=\u00a0\u00bb|||\u00a0\u00bb][et_pb_text _builder_version=\u00a0\u00bb4.24.3&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb header_2_line_height=\u00a0\u00bb1.3em\u00a0\u00bb header_3_line_height=\u00a0\u00bb1.1em\u00a0\u00bb header_4_line_height=\u00a0\u00bb1.3em\u00a0\u00bb custom_margin=\u00a0\u00bb0px||||false|false\u00a0\u00bb custom_padding=\u00a0\u00bb0px||||false|false\u00a0\u00bb header_3_line_height_tablet=\u00a0\u00bb1.1em\u00a0\u00bb header_3_line_height_phone=\u00a0\u00bb1.1em\u00a0\u00bb header_3_line_height_last_edited=\u00a0\u00bbon|tablet\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<h2>Explorer les donn\u00e9es synth\u00e9tiques : red\u00e9finir la protection de la vie priv\u00e9e dans l\u2019innovation  <\/h2>\n<p>La vid\u00e9o explique ce que sont les donn\u00e9es synth\u00e9tiques et comment elles pourraient \u00eatre b\u00e9n\u00e9fiques pour la recherche m\u00e9dicale, y compris la possibilit\u00e9 pour le projet OPTIMA de g\u00e9n\u00e9rer des donn\u00e9es synth\u00e9tiques, permettant l\u2019innovation et la prise de d\u00e9cision sans compromettre la vie priv\u00e9e.<\/p>\n<p>[\/et_pb_text][et_pb_code admin_label=\u00a0\u00bbAdmin &#8211; Ne pas supprimer\u00a0\u00bb module_class=\u00a0\u00bbpostcontent  \u00a0\u00bb _builder_version=\u00a0\u00bb4.21.0&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<div class=\"currentpostcategory\">tout<\/div>\n<p>[\/et_pb_code][\/et_pb_column][et_pb_column type=\u00a0\u00bb2_5&Prime; _builder_version=\u00a0\u00bb4.16&Prime; custom_padding=\u00a0\u00bb|||\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb custom_padding__hover=\u00a0\u00bb|||\u00a0\u00bb][et_pb_video src=\u00a0\u00bbhttps:\/\/youtu.be\/5mgRSip58SY\u00a0\u00bb _builder_version=\u00a0\u00bb4.24.3&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb custom_margin=\u00a0\u00bb4px||||false|false\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][\/et_pb_video][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00a0\u00bb3_5,2_5&Prime; admin_label=\u00a0\u00bbL\u2019IA dans les soins de sant\u00e9\u00a0\u00bb _builder_version=\u00a0\u00bb4.24.3&Prime; background_size=\u00a0\u00bbinitial\u00a0\u00bb background_position=\u00a0\u00bbtop_left\u00a0\u00bb background_repeat=\u00a0\u00bbrepeat\u00a0\u00bb custom_margin=\u00a0\u00bb||||false|false\u00a0\u00bb custom_margin_tablet=\u00a0\u00bb||60px||false|false\u00a0\u00bb custom_margin_phone=\u00a0\u00bb||60px||false|false\u00a0\u00bb custom_margin_last_edited=\u00a0\u00bbon|tablet\u00a0\u00bb collapsed=\u00a0\u00bbon\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_column type=\u00a0\u00bb3_5&Prime; _builder_version=\u00a0\u00bb4.16&Prime; custom_padding=\u00a0\u00bb|||\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb custom_padding__hover=\u00a0\u00bb|||\u00a0\u00bb][et_pb_text _builder_version=\u00a0\u00bb4.24.3&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb header_2_line_height=\u00a0\u00bb1.3em\u00a0\u00bb header_3_line_height=\u00a0\u00bb1.1em\u00a0\u00bb header_4_line_height=\u00a0\u00bb1.3em\u00a0\u00bb custom_margin=\u00a0\u00bb0px||||false|false\u00a0\u00bb custom_padding=\u00a0\u00bb0px||||false|false\u00a0\u00bb header_3_line_height_tablet=\u00a0\u00bb1.1em\u00a0\u00bb header_3_line_height_phone=\u00a0\u00bb1.1em\u00a0\u00bb header_3_line_height_last_edited=\u00a0\u00bbon|tablet\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<h2>L\u2019intelligence artificielle dans les soins de sant\u00e9  <\/h2>\n<p>La vid\u00e9o pr\u00e9sente bri\u00e8vement les aspects de l\u2019IA dans les soins de sant\u00e9 et comment les patients peuvent b\u00e9n\u00e9ficier des d\u00e9veloppements d\u2019OPTIMA.<\/p>\n<p>[\/et_pb_text][et_pb_code admin_label=\u00a0\u00bbAdmin &#8211; Ne pas supprimer\u00a0\u00bb module_class=\u00a0\u00bbpostcontent  \u00a0\u00bb _builder_version=\u00a0\u00bb4.21.0&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<div class=\"currentpostcategory\">tout<\/div>\n<p>[\/et_pb_code][\/et_pb_column][et_pb_column type=\u00a0\u00bb2_5&Prime; _builder_version=\u00a0\u00bb4.16&Prime; custom_padding=\u00a0\u00bb|||\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb custom_padding__hover=\u00a0\u00bb|||\u00a0\u00bb][et_pb_video src=\u00a0\u00bbhttps:\/\/youtu.be\/g0aAC1QpbdM\u00a0\u00bb _builder_version=\u00a0\u00bb4.24.3&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb custom_margin=\u00a0\u00bb4px||||false|false\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][\/et_pb_video][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00a0\u00bb3_5,2_5&Prime; admin_label=\u00a0\u00bbPr\u00e9jug\u00e9s injustes\u00a0\u00bb _builder_version=\u00a0\u00bb4.23.1&Prime; background_size=\u00a0\u00bbinitial\u00a0\u00bb background_position=\u00a0\u00bbtop_left\u00a0\u00bb background_repeat=\u00a0\u00bbrepeat\u00a0\u00bb custom_margin=\u00a0\u00bb||||false|false\u00a0\u00bb custom_margin_tablet=\u00a0\u00bb||60px||false|false\u00a0\u00bb custom_margin_phone=\u00a0\u00bb||60px||false|false\u00a0\u00bb custom_margin_last_edited=\u00a0\u00bbon|tablet\u00a0\u00bb collapsed=\u00a0\u00bbon\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_column type=\u00a0\u00bb3_5&Prime; _builder_version=\u00a0\u00bb4.16&Prime; custom_padding=\u00a0\u00bb|||\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb custom_padding__hover=\u00a0\u00bb|||\u00a0\u00bb][et_pb_text _builder_version=\u00a0\u00bb4.24.3&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb header_2_line_height=\u00a0\u00bb1.3em\u00a0\u00bb header_3_line_height=\u00a0\u00bb1.1em\u00a0\u00bb header_4_line_height=\u00a0\u00bb1.3em\u00a0\u00bb custom_margin=\u00a0\u00bb0px||||false|false\u00a0\u00bb custom_padding=\u00a0\u00bb0px||||false|false\u00a0\u00bb header_3_line_height_tablet=\u00a0\u00bb1.1em\u00a0\u00bb header_3_line_height_phone=\u00a0\u00bb1.1em\u00a0\u00bb header_3_line_height_last_edited=\u00a0\u00bbon|tablet\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<h2>Pr\u00e9jug\u00e9s injustes dans l\u2019intelligence artificielle<\/h2>\n<p>La vid\u00e9o d\u00e9crit ce qu\u2019est un biais injuste et quel r\u00f4le il joue dans le d\u00e9veloppement et l\u2019interaction avec les syst\u00e8mes d\u2019IA.<\/p>\n<p>[\/et_pb_text][et_pb_code admin_label=\u00a0\u00bbAdmin &#8211; Ne pas supprimer\u00a0\u00bb module_class=\u00a0\u00bbpostcontent  \u00a0\u00bb _builder_version=\u00a0\u00bb4.21.0&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<div class=\"currentpostcategory\">tout<\/div>\n<p>[\/et_pb_code][\/et_pb_column][et_pb_column type=\u00a0\u00bb2_5&Prime; _builder_version=\u00a0\u00bb4.16&Prime; custom_padding=\u00a0\u00bb|||\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb custom_padding__hover=\u00a0\u00bb|||\u00a0\u00bb][et_pb_video src=\u00a0\u00bbhttps:\/\/youtu.be\/Rtpvr3_n_hY\u00a0\u00bb _builder_version=\u00a0\u00bb4.24.3&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb custom_margin=\u00a0\u00bb4px||||false|false\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][\/et_pb_video][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=\u00a0\u00bb1&Prime; admin_label=\u00a0\u00bbIntegration Publications\u00a0\u00bb _builder_version=\u00a0\u00bb4.23.1&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb da_disable_devices=\u00a0\u00bboff|off|off\u00a0\u00bb collapsed=\u00a0\u00bboff\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb da_is_popup=\u00a0\u00bboff\u00a0\u00bb da_exit_intent=\u00a0\u00bboff\u00a0\u00bb da_has_close=\u00a0\u00bbon\u00a0\u00bb da_alt_close=\u00a0\u00bboff\u00a0\u00bb da_dark_close=\u00a0\u00bboff\u00a0\u00bb da_not_modal=\u00a0\u00bbon\u00a0\u00bb da_is_singular=\u00a0\u00bboff\u00a0\u00bb da_with_loader=\u00a0\u00bboff\u00a0\u00bb da_has_shadow=\u00a0\u00bbon\u00a0\u00bb][et_pb_row _builder_version=\u00a0\u00bb4.23.1&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_column type=\u00a0\u00bb4_4&Prime; _builder_version=\u00a0\u00bb4.23.1&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_text _builder_version=\u00a0\u00bb4.24.3&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb header_2_font=\u00a0\u00bb|700|||||||\u00a0\u00bb header_2_text_align=\u00a0\u00bbcenter\u00a0\u00bb header_2_line_height=\u00a0\u00bb120%\u00a0\u00bb header_4_line_height=\u00a0\u00bb1.3em\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<h2 style=\"text-align: left;\">Documents Publics<\/h2>\n<p>Vous trouverez ci-dessous des liens vers tous les documents publics finalis\u00e9s du consortium OPTIMA:<\/p>\n<ul>\n<li><a href=\"https:\/\/www.optima-oncology.eu\/wp-content\/uploads\/OPTIMA_D2.2_Initial-report-on-the-legal-and-ethical-framework-of-the-project.pdf\">D2.2 Initial report on the legal and ethical framework of the project<\/a><\/li>\n<li><a href=\"https:\/\/www.optima-oncology.eu\/wp-content\/uploads\/OPTIMA_D3.1_A-report-on-identified-research-questions-and-guidelines-including-process-of-selection-and-prioritisation.pdf\">D3.1 A report on identified research questions and guidelines, including process of selection and prioritisation<\/a><\/li>\n<li><a href=\"https:\/\/www.optima-oncology.eu\/wp-content\/uploads\/OPTIMA_D5.1_User-personas-and-champions-identified.pdf\">D5.1 User personas &amp; champions identified<\/a><\/li>\n<li><a href=\"https:\/\/www.optima-oncology.eu\/wp-content\/uploads\/OPTIMA_D8.3_Report-on-project-specific-website-and-social-media-platforms.pdf\">D8.3 Report on project-specific website and social media platforms<\/a><\/li>\n<\/ul>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00a0\u00bb4.23.1&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_column type=\u00a0\u00bb4_4&Prime; _builder_version=\u00a0\u00bb4.23.1&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_text _builder_version=\u00a0\u00bb4.24.3&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb text_orientation=\u00a0\u00bbcenter\u00a0\u00bb hover_enabled=\u00a0\u00bb0&Prime; global_colors_info=\u00a0\u00bb{}\u00a0\u00bb sticky_enabled=\u00a0\u00bb0&Prime;]<\/p>\n<h2 style=\"text-align: left;\">Publications<\/h2>\n<p style=\"text-align: left;\">George Corby, Nicola L. Barclay, Eng Hooi Tan, Edward Burn, Antonella Delmestri, Talita Duarte-Salles, Asieh Golozar, Wai Yi Man, Ilona Tietzova, Daniel Prieto-Alhambra. Danielle Newby. <strong>Incidence, prevalence, and survival of lung cancer in the United Kingdom from 2000\u20132021: a population-based cohort study<\/strong>. Translational Lung Cancer Research. Vol 13, No 9 (September 30, 2024)\u00a0<a href=\"https:\/\/tlcr.amegroups.org\/article\/view\/90838\/html\">doi: 10.21037\/tlcr-24-241<\/a><\/p>\n<p style=\"text-align: left;\">Barclay Nicola L., Pineda Moncus\u00ed Marta, J\u00f6dicke Annika M., Prieto-Alhambra Daniel, Ravent\u00f3s Berta, Newby Danielle, Delmestri Antonella, Man Wai Yi, Chen Xihang, Catal\u00e0 Marti. <strong>The impact of the UK COVID-19 lockdown on the screening, diagnostics and incidence of breast, colorectal, lung and prostate cancer in the UK: a population-based cohort study. <\/strong>Frontiers in Oncology. 2024, vol. 14, <a href=\"https:\/\/www.frontiersin.org\/journals\/oncology\/articles\/10.3389\/fonc.2024.1370862\/full\">DOI=10.3389\/fonc.2024.1370862<\/a><\/p>\n<p style=\"text-align: left;\"><span class=\"TextRun SCXP33389798 BCX8\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun SCXP33389798 BCX8\">Barclay Nicola L., Pineda <\/span><\/span><span class=\"TextRun SpellingErrorZoomed SCXP33389798 BCX8\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"SCXP33389798 BCX8\">Moncus\u00ed<\/span><\/span><span class=\"TextRun SCXP33389798 BCX8\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun SCXP33389798 BCX8\"> Marta, J\u00f6dicke Annika M., Prieto-Alhambra Daniel, <\/span><\/span><span class=\"TextRun SpellingErrorZoomed SCXP33389798 BCX8\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"SCXP33389798 BCX8\">Ravent\u00f3s<\/span><\/span><span class=\"TextRun SpellingErrorZoomed SCXP33389798 BCX8\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun SCXP33389798 BCX8\"> Berta, <\/span><span class=\"SCXP33389798 BCX8\">Newby<\/span><span class=\"NormalTextRun SCXP33389798 BCX8\"> Danielle, <\/span><span class=\"SCXP33389798 BCX8\">Delmestri<\/span><span class=\"NormalTextRun SCXP33389798 BCX8\"> Antonella, <\/span><\/span><span class=\"TextRun SCXP33389798 BCX8\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun SCXP33389798 BCX8\">Man Wai Yi, Chen <\/span><\/span><span class=\"TextRun SpellingErrorZoomed SCXP33389798 BCX8\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"SCXP33389798 BCX8\">Xihang<\/span><\/span><span class=\"TextRun SCXP33389798 BCX8\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun SCXP33389798 BCX8\">, <\/span><\/span><span class=\"TextRun SpellingErrorZoomed SCXP33389798 BCX8\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"SCXP33389798 BCX8\">Catal\u00e0<\/span><\/span><span class=\"TextRun SCXP33389798 BCX8\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun SCXP33389798 BCX8\"> Marti. <\/span><\/span><strong><span class=\"TextRun SCXP33389798 BCX8\" lang=\"EN-US\" xml:lang=\"EN-US\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun SCXP33389798 BCX8\">The impact of the UK COVID-19 lockdown on the screening, diagnostics and incidence of breast, <\/span><\/span><span class=\"TextRun SCXP33389798 BCX8\" lang=\"EN-US\" xml:lang=\"EN-US\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun SCXP33389798 BCX8\">colorectal, lung and prostate cancer in the UK: a population-based cohort study. <\/span><\/span><\/strong><span class=\"TextRun SpellingErrorZoomed SCXP33389798 BCX8\" lang=\"IT-IT\" xml:lang=\"IT-IT\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"SCXP33389798 BCX8\">Frontiers<\/span><\/span><span class=\"TextRun SCXP33389798 BCX8\" lang=\"IT-IT\" xml:lang=\"IT-IT\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun SCXP33389798 BCX8\"> in <\/span><\/span><span class=\"TextRun SpellingErrorZoomed SCXP33389798 BCX8\" lang=\"IT-IT\" xml:lang=\"IT-IT\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"SCXP33389798 BCX8\">Oncology<\/span><\/span><span class=\"TextRun SCXP33389798 BCX8\" lang=\"IT-IT\" xml:lang=\"IT-IT\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun SCXP33389798 BCX8\">. 2024, vol. 14, <\/span><\/span><a href=\"https:\/\/www.frontiersin.org\/journals\/oncology\/articles\/10.3389\/fonc.2024.1370862\/full\"><span class=\"TextRun SCXP33389798 BCX8\" lang=\"IT-IT\" xml:lang=\"IT-IT\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun SCXP33389798 BCX8\">DOI=10.3389\/fonc.2024.1370862<\/span><\/span><\/a><\/p>\n<p style=\"text-align: left;\"><span class=\"EOP SCXP33389798 BCX8\"><span class=\"TextRun SCXP18682443 BCX8\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun SCXP18682443 BCX8\">E. <\/span><\/span><span class=\"TextRun SpellingErrorZoomed SCXP18682443 BCX8\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"SCXP18682443 BCX8\">Lavrova<\/span><\/span><span class=\"TextRun SCXP18682443 BCX8\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun SCXP18682443 BCX8\"> et al., \u00ab\u00a0<strong>UR-<\/strong><\/span><\/span><strong><span class=\"TextRun SpellingErrorZoomed SCXP18682443 BCX8\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"SCXP18682443 BCX8\">CarA<\/span><\/span><span class=\"TextRun SCXP18682443 BCX8\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun SCXP18682443 BCX8\">-Net: A <\/span><\/span><span class=\"TextRun SpellingErrorZoomed SCXP18682443 BCX8\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"SCXP18682443 BCX8\">Cascaded<\/span><\/span><span class=\"TextRun SCXP18682443 BCX8\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun SCXP18682443 BCX8\"> Framework <\/span><\/span><span class=\"TextRun SCXP18682443 BCX8\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun SCXP18682443 BCX8\">With<\/span><\/span> <span class=\"TextRun SpellingErrorZoomed SCXP18682443 BCX8\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"SCXP18682443 BCX8\">Uncertainty<\/span><\/span> <span class=\"TextRun SpellingErrorZoomed SCXP18682443 BCX8\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"SCXP18682443 BCX8\">Regularization<\/span><\/span><span class=\"TextRun SpellingErrorZoomed SCXP18682443 BCX8\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"> <span class=\"SCXP18682443 BCX8\">for<\/span> <\/span><span class=\"TextRun SpellingErrorZoomed SCXP18682443 BCX8\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"SCXP18682443 BCX8\">Automated<\/span><\/span><span class=\"TextRun SCXP18682443 BCX8\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun SCXP18682443 BCX8\"> Segmentation <\/span><\/span><span class=\"TextRun SpellingErrorZoomed SCXP18682443 BCX8\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"SCXP18682443 BCX8\">of<\/span><\/span> <span class=\"TextRun SpellingErrorZoomed SCXP18682443 BCX8\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"SCXP18682443 BCX8\">Carotid<\/span><\/span> <span class=\"TextRun SpellingErrorZoomed SCXP18682443 BCX8\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"SCXP18682443 BCX8\">Arteries<\/span><\/span><span class=\"TextRun SCXP18682443 BCX8\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun SCXP18682443 BCX8\"> on <\/span><\/span><\/strong><span class=\"TextRun SCXP18682443 BCX8\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun SCXP18682443 BCX8\"><strong>Black Blood MR Images<\/strong>,\u00a0\u00bb in <\/span><span class=\"ContextualSpellingAndGrammarErrorZoomed SCXP18682443 BCX8\">IEEE Access<\/span><span class=\"NormalTextRun SCXP18682443 BCX8\">, vol. 11, pp. 26637-26651, 2023, <\/span><\/span><a href=\"https:\/\/ieeexplore.ieee.org\/document\/10073528\"><span class=\"TextRun SpellingErrorZoomed SCXP18682443 BCX8\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"SCXP18682443 BCX8\">doi<\/span><\/span><\/a><span class=\"TextRun SCXP18682443 BCX8\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun SCXP18682443 BCX8\">: 10.1109\/ACCESS.2023.3258408.<\/span><\/span><br \/><\/span><\/p>\n<p style=\"text-align: left;\"><span class=\"TextRun SpellingErrorZoomed  BCX8 SCXP179426825\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"BCX8 SCXP179426825\">Salahuddin<\/span><\/span><span class=\"TextRun SpellingErrorZoomed  BCX8 SCXP179426825\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun  BCX8 SCXP179426825\">, Z.; Chen, Y.; Zhong, X.; Woodruff, H.C.; Rad, N.M.; Mali, S.A.; <\/span><span class=\"BCX8 SCXP179426825\">Lambin<\/span><span class=\"NormalTextRun  BCX8 SCXP179426825\">, P. <\/span><\/span><strong><span class=\"TextRun SpellingErrorZoomed  BCX8 SCXP179426825\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"BCX8 SCXP179426825\">From<\/span><\/span><span class=\"TextRun  BCX8 SCXP179426825\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun  BCX8 SCXP179426825\"> Head and Neck <\/span><\/span><span class=\"TextRun SpellingErrorZoomed  BCX8 SCXP179426825\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"BCX8 SCXP179426825\">Tumour<\/span><\/span><span class=\"TextRun  BCX8 SCXP179426825\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun  BCX8 SCXP179426825\"> and <\/span><\/span><span class=\"TextRun SpellingErrorZoomed  BCX8 SCXP179426825\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"BCX8 SCXP179426825\">Lymph<\/span><\/span><span class=\"TextRun  BCX8 SCXP179426825\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun  BCX8 SCXP179426825\"> Node <\/span><\/span><span class=\"TextRun  BCX8 SCXP179426825\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun  BCX8 SCXP179426825\">Segmentation <\/span><\/span><span class=\"TextRun SpellingErrorZoomed  BCX8 SCXP179426825\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"BCX8 SCXP179426825\">to<\/span><\/span><span class=\"TextRun  BCX8 SCXP179426825\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun  BCX8 SCXP179426825\"> Survival <\/span><\/span><span class=\"TextRun SpellingErrorZoomed  BCX8 SCXP179426825\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"BCX8 SCXP179426825\">Prediction<\/span><\/span><span class=\"TextRun  BCX8 SCXP179426825\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun  BCX8 SCXP179426825\"> on PET\/CT: An End-<\/span><\/span><span class=\"TextRun SpellingErrorZoomed  BCX8 SCXP179426825\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"BCX8 SCXP179426825\">to<\/span><\/span><span class=\"TextRun  BCX8 SCXP179426825\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun  BCX8 SCXP179426825\">-End Framework <\/span><\/span><span class=\"TextRun SpellingErrorZoomed  BCX8 SCXP179426825\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"BCX8 SCXP179426825\">Featuring<\/span><\/span> <span class=\"TextRun SpellingErrorZoomed  BCX8 SCXP179426825\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"BCX8 SCXP179426825\">Uncertainty<\/span><\/span><span class=\"TextRun  BCX8 SCXP179426825\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun  BCX8 SCXP179426825\">, Fairness, and Multi-Region Multi-Modal <\/span><\/span><span class=\"TextRun SpellingErrorZoomed  BCX8 SCXP179426825\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"BCX8 SCXP179426825\">Radiomics<\/span><\/span><\/strong><span class=\"TextRun  BCX8 SCXP179426825\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun  BCX8 SCXP179426825\"><strong>.<\/strong> Cancers 2023, 15, 1932. <a href=\"https:\/\/doi.org\/10.3390\/cancers15071932\">https:\/\/doi.org\/10.3390\/cancers15071932<\/a><\/span><\/span><\/p>\n<p style=\"text-align: left;\"><span class=\"TextRun SpellingErrorZoomed  BCX8 SCXP175012020\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"BCX8 SCXP175012020\">N\u2019Dow<\/span><\/span><span class=\"TextRun SpellingErrorZoomed  BCX8 SCXP175012020\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun  BCX8 SCXP175012020\"> J., Smith E.J., <\/span><span class=\"BCX8 SCXP175012020\">Polychronopoulos<\/span><span class=\"NormalTextRun  BCX8 SCXP175012020\"> K., Cannon A., <\/span><span class=\"BCX8 SCXP175012020\">Roobol<\/span><span class=\"NormalTextRun  BCX8 SCXP175012020\"> M. J., <\/span><span class=\"BCX8 SCXP175012020\">Auweter<\/span><span class=\"NormalTextRun  BCX8 SCXP175012020\"> S., Thomas M., Kremer A., De <\/span><span class=\"BCX8 SCXP175012020\">Meulder<\/span><span class=\"NormalTextRun  BCX8 SCXP175012020\"> B., <\/span><span class=\"BCX8 SCXP175012020\">Dellamonica<\/span><span class=\"NormalTextRun  BCX8 SCXP175012020\"> D., <\/span><\/span><span class=\"TextRun  BCX8 SCXP175012020\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun  BCX8 SCXP175012020\">Prieto-Alhambra D., <\/span><\/span><span class=\"TextRun SpellingErrorZoomed  BCX8 SCXP175012020\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"BCX8 SCXP175012020\">Asiimwe<\/span><\/span><span class=\"TextRun SpellingErrorZoomed  BCX8 SCXP175012020\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun  BCX8 SCXP175012020\"> A., <\/span><span class=\"BCX8 SCXP175012020\">Bussmann<\/span><span class=\"NormalTextRun  BCX8 SCXP175012020\"> M., Xiang J., <\/span><span class=\"BCX8 SCXP175012020\">Torremante<\/span><span class=\"NormalTextRun  BCX8 SCXP175012020\"> P., Keller S., Kube F., Kr\u00fcger H., OPTIMA <\/span><\/span><span class=\"TextRun SpellingErrorZoomed  BCX8 SCXP175012020\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"BCX8 SCXP175012020\">Consortium<\/span><\/span><span class=\"TextRun  BCX8 SCXP175012020\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun  BCX8 SCXP175012020\">. (2022) <\/span><\/span><strong><span class=\"TextRun  BCX8 SCXP175012020\" lang=\"EN-US\" xml:lang=\"EN-US\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun  BCX8 SCXP175012020\">OPTIMA: <\/span><\/span><span class=\"TextRun  BCX8 SCXP175012020\" lang=\"EN-US\" xml:lang=\"EN-US\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun  BCX8 SCXP175012020\">Improve care for patients with prostate, breast, and lung cancer through artificial intelligence<\/span><\/span><\/strong> <span class=\"TextRun  BCX8 SCXP175012020\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun  BCX8 SCXP175012020\">ESMO <\/span><\/span><span class=\"TextRun  BCX8 SCXP175012020\" lang=\"EN-US\" xml:lang=\"EN-US\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun  BCX8 SCXP175012020\">#917P <\/span><\/span><a class=\"Hyperlink  BCX8 SCXP175012020\" href=\"https:\/\/cslide.ctimeetingtech.com\/esmo2022\/attendee\/confcal_2\/presentation\/list?q=917p\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"TextRun  BCX8 SCXP175012020\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun  BCX8 SCXP175012020\">e-Posters &#8211; ESMO <\/span><\/span><\/a><a class=\"Hyperlink  BCX8 SCXP175012020\" href=\"https:\/\/cslide.ctimeetingtech.com\/esmo2022\/attendee\/confcal_2\/presentation\/list?q=917p\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"TextRun  BCX8 SCXP175012020\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun  BCX8 SCXP175012020\">Congress<\/span><\/span><\/a><a class=\"Hyperlink  BCX8 SCXP175012020\" href=\"https:\/\/cslide.ctimeetingtech.com\/esmo2022\/attendee\/confcal_2\/presentation\/list?q=917p\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"TextRun  BCX8 SCXP175012020\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun  BCX8 SCXP175012020\"> 2022 <\/span><\/span><\/a><a class=\"Hyperlink  BCX8 SCXP175012020\" href=\"https:\/\/cslide.ctimeetingtech.com\/esmo2022\/attendee\/confcal_2\/presentation\/list?q=917p\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"TextRun  BCX8 SCXP175012020\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun  BCX8 SCXP175012020\">(ctimeetingtech.com)<\/span><\/span><\/a><\/p>\n<p style=\"text-align: left;\"><span class=\"TextRun SpellingErrorZoomed  BCX8 SCXP267898365\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"BCX8 SCXP267898365\">Refaee<\/span><\/span><span class=\"TextRun  BCX8 SCXP267898365\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun  BCX8 SCXP267898365\">, T., <\/span><\/span><span class=\"TextRun SpellingErrorZoomed  BCX8 SCXP267898365\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"BCX8 SCXP267898365\">Bondue<\/span><\/span><span class=\"TextRun  BCX8 SCXP267898365\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun  BCX8 SCXP267898365\">, B., Van <\/span><\/span><span class=\"TextRun SpellingErrorZoomed  BCX8 SCXP267898365\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"BCX8 SCXP267898365\">Simaeys<\/span><\/span><span class=\"TextRun SpellingErrorZoomed  BCX8 SCXP267898365\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun  BCX8 SCXP267898365\">, G., Wu, G., Yan, C., Woodruff, H. C., Goldman, S., &amp; <\/span><span class=\"BCX8 SCXP267898365\">Lambin<\/span><span class=\"NormalTextRun  BCX8 SCXP267898365\">, P. (2022). <strong>A <\/strong><\/span><\/span><strong><span class=\"TextRun SpellingErrorZoomed  BCX8 SCXP267898365\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"BCX8 SCXP267898365\">Handcrafted<\/span><\/span> <span class=\"TextRun SpellingErrorZoomed  BCX8 SCXP267898365\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"BCX8 SCXP267898365\">Radiomics-<\/span><\/span><span class=\"TextRun SpellingErrorZoomed  BCX8 SCXP267898365\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"BCX8 SCXP267898365\">Based<\/span><\/span><span class=\"TextRun SpellingErrorZoomed  BCX8 SCXP267898365\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun  BCX8 SCXP267898365\"> Model <\/span><span class=\"BCX8 SCXP267898365\">for<\/span> <\/span><span class=\"TextRun SpellingErrorZoomed  BCX8 SCXP267898365\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"BCX8 SCXP267898365\">the<\/span><\/span><span class=\"TextRun  BCX8 SCXP267898365\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun  BCX8 SCXP267898365\"> Diagnosis <\/span><\/span><span class=\"TextRun SpellingErrorZoomed  BCX8 SCXP267898365\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"BCX8 SCXP267898365\">of<\/span><\/span> <span class=\"TextRun SpellingErrorZoomed  BCX8 SCXP267898365\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"BCX8 SCXP267898365\">Usual<\/span><\/span><span class=\"TextRun  BCX8 SCXP267898365\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun  BCX8 SCXP267898365\"> Interstitial <\/span><\/span><span class=\"TextRun SpellingErrorZoomed  BCX8 SCXP267898365\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"BCX8 SCXP267898365\">Pneumonia<\/span><\/span><span class=\"TextRun  BCX8 SCXP267898365\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun  BCX8 SCXP267898365\"> in <\/span><\/span><span class=\"TextRun SpellingErrorZoomed  BCX8 SCXP267898365\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"BCX8 SCXP267898365\">Patients<\/span><\/span> <span class=\"TextRun SpellingErrorZoomed  BCX8 SCXP267898365\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"BCX8 SCXP267898365\">with<\/span><\/span> <span class=\"TextRun SpellingErrorZoomed  BCX8 SCXP267898365\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"BCX8 SCXP267898365\">Idiopathic<\/span><\/span> <span class=\"TextRun SpellingErrorZoomed  BCX8 SCXP267898365\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"BCX8 SCXP267898365\">Pulmonary<\/span><\/span> <span class=\"TextRun SpellingErrorZoomed  BCX8 SCXP267898365\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"BCX8 SCXP267898365\">Fibrosis<\/span><\/span><\/strong><span class=\"TextRun  BCX8 SCXP267898365\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun  BCX8 SCXP267898365\">. J Pers <\/span><\/span><span class=\"TextRun SpellingErrorZoomed  BCX8 SCXP267898365\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"BCX8 SCXP267898365\">Med<\/span><\/span><span class=\"TextRun  BCX8 SCXP267898365\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun  BCX8 SCXP267898365\">, 12(3). <\/span><\/span><a href=\"https:\/\/doi.org\/10.3390\/jpm12030373\"><span class=\"TextRun  BCX8 SCXP267898365\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun  BCX8 SCXP267898365\">https:\/\/doi.org\/10.3390\/jpm12030373<\/span><\/span><\/a><\/p>\n<p style=\"text-align: left;\" data-ccp-props=\"{&quot;335551550&quot;:1,&quot;335551620&quot;:1,&quot;335559683&quot;:0,&quot;335559685&quot;:0,&quot;335559731&quot;:0,&quot;335559737&quot;:0,&quot;335562764&quot;:2,&quot;335562765&quot;:0.9,&quot;335562766&quot;:4,&quot;335562767&quot;:10,&quot;335562768&quot;:4,&quot;335562769&quot;:0}\"><span data-usefontface=\"false\" data-contrast=\"none\">Li, R., Sharma, V., <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Thangamani<\/span><span data-usefontface=\"false\" data-contrast=\"none\">, S., &amp; <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Yakimovich<\/span><span data-usefontface=\"false\" data-contrast=\"none\">, A. (2022). <strong>Open-Source Biomedical Image Analysis Models: A Meta-Analysis and <\/strong><\/span><strong>Continuous<\/strong><span data-usefontface=\"false\" data-contrast=\"none\"><strong> Survey.<\/strong> Front <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Bioinform<\/span><span data-usefontface=\"false\" data-contrast=\"none\">, 2, 912809. <a href=\"https:\/\/doi.org\/10.3389\/fbinf.2022.912809\">https:\/\/doi.org\/10.3389\/fbinf.2022.912809<\/a>\u00a0 <\/span>\u200b<\/p>\n<p style=\"text-align: left;\" data-ccp-props=\"{&quot;335551550&quot;:1,&quot;335551620&quot;:1,&quot;335559683&quot;:0,&quot;335559685&quot;:0,&quot;335559731&quot;:0,&quot;335559737&quot;:0,&quot;335562764&quot;:2,&quot;335562765&quot;:0.9,&quot;335562766&quot;:4,&quot;335562767&quot;:10,&quot;335562768&quot;:4,&quot;335562769&quot;:0}\"><span data-usefontface=\"false\" data-contrast=\"none\">Halilaj<\/span><span data-usefontface=\"false\" data-contrast=\"none\"> I, <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Oberije<\/span><span data-usefontface=\"false\" data-contrast=\"none\"> C, Chatterjee A, van <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Wijk<\/span><span data-usefontface=\"false\" data-contrast=\"none\"> Y, Rad NM, <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Galganebanduge<\/span><span data-usefontface=\"false\" data-contrast=\"none\"> P, <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Lavrova<\/span><span data-usefontface=\"false\" data-contrast=\"none\"> E, <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Primakov<\/span><span data-usefontface=\"false\" data-contrast=\"none\"> S, <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Widaatalla<\/span><span data-usefontface=\"false\" data-contrast=\"none\"> Y, Wind A, Lambin P. <strong>Open <\/strong><\/span><strong>Source Repository and Online Calculator of Prediction Models for Diagnosis and Prognosis in Oncology. <\/strong><span data-usefontface=\"false\" data-contrast=\"none\">Biomedicines<\/span><span data-usefontface=\"false\" data-contrast=\"none\">. 2022 <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Oct<\/span> <span data-usefontface=\"false\" data-contrast=\"none\">23;10(11):2679. <\/span><a href=\"https:\/\/www.mdpi.com\/2227-9059\/10\/11\/2679\"><span data-usefontface=\"false\" data-contrast=\"none\">doi<\/span><\/a><span data-usefontface=\"false\" data-contrast=\"none\">: 10.3390\/biomedicines10112679. PMID: 36359199; PMCID: PMC9687260.<\/span>\u200b<\/p>\n<p style=\"text-align: left;\" data-ccp-props=\"{&quot;335551550&quot;:1,&quot;335551620&quot;:1,&quot;335559683&quot;:0,&quot;335559685&quot;:0,&quot;335559731&quot;:0,&quot;335559737&quot;:0,&quot;335562764&quot;:2,&quot;335562765&quot;:0.9,&quot;335562766&quot;:4,&quot;335562767&quot;:10,&quot;335562768&quot;:4,&quot;335562769&quot;:0}\"><span data-usefontface=\"false\" data-contrast=\"none\">Refaee<\/span><span data-usefontface=\"false\" data-contrast=\"none\">, T.; <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Salahuddin<\/span><span data-usefontface=\"false\" data-contrast=\"none\">, Z.; <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Widaatalla<\/span><span data-usefontface=\"false\" data-contrast=\"none\">, Y.; <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Primakov<\/span><span data-usefontface=\"false\" data-contrast=\"none\">, S.; Woodruff, H.C.; <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Hustinx<\/span><span data-usefontface=\"false\" data-contrast=\"none\">, R.; <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Mottaghy<\/span><span data-usefontface=\"false\" data-contrast=\"none\">, F.M.; Ibrahim, A.; Lambin, P. <strong>CT <\/strong><\/span><strong>Reconstruction Kernels and the Effect of Pre- and Post-Processing on the Reproducibility of Handcrafted Radiomic<\/strong><span data-usefontface=\"false\" data-contrast=\"none\"><strong> Features<\/strong>. J. Pers. Med. <\/span><span data-usefontface=\"false\" data-contrast=\"none\">2022, 12, 553. <a href=\"https:\/\/doi.org\/10.3390\/jpm12040553\">https:\/\/doi.org\/10.3390\/jpm12040553<\/a><\/span>\u200b<\/p>\n<p style=\"text-align: left;\" data-ccp-props=\"{&quot;335551550&quot;:1,&quot;335551620&quot;:1,&quot;335559683&quot;:0,&quot;335559685&quot;:0,&quot;335559731&quot;:0,&quot;335559737&quot;:0,&quot;335562764&quot;:2,&quot;335562765&quot;:0.9,&quot;335562766&quot;:4,&quot;335562767&quot;:10,&quot;335562768&quot;:4,&quot;335562769&quot;:0}\"><span data-usefontface=\"false\" data-contrast=\"none\">Refaee<\/span><span data-usefontface=\"false\" data-contrast=\"none\">, T., <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Salahuddin<\/span><span data-usefontface=\"false\" data-contrast=\"none\">, Z., <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Frix<\/span><span data-usefontface=\"false\" data-contrast=\"none\">, A.-N., Yan, C., Wu, G., Woodruff, H. C., <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Gietema<\/span><span data-usefontface=\"false\" data-contrast=\"none\">, H., Meunier, P., Louis, R., <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Guiot<\/span><span data-usefontface=\"false\" data-contrast=\"none\">, J., &amp; Lambin, P. (2022). <\/span><strong>Diagnosis of Idiopathic Pulmonary Fibrosis in High-Resolution Computed Tomography Scans Using a Combination of Handcrafted Radiomics <\/strong><span data-usefontface=\"false\" data-contrast=\"none\"><strong>and Deep Learning<\/strong> [Original Research]. Frontiers in Medicine, 9. <a href=\"https:\/\/doi.org\/10.3389\/fmed.2022.915243\">https:\/\/doi.org\/10.3389\/fmed.2022.915243 <\/a><\/span>\u200b<\/p>\n<p style=\"text-align: left;\" data-ccp-props=\"{&quot;335551550&quot;:1,&quot;335551620&quot;:1,&quot;335559683&quot;:0,&quot;335559685&quot;:0,&quot;335559731&quot;:0,&quot;335559737&quot;:0,&quot;335562764&quot;:2,&quot;335562765&quot;:0.9,&quot;335562766&quot;:4,&quot;335562767&quot;:10,&quot;335562768&quot;:4,&quot;335562769&quot;:0}\"><span data-usefontface=\"false\" data-contrast=\"none\">Keek<\/span><span data-usefontface=\"false\" data-contrast=\"none\"> SA, <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Beuque<\/span><span data-usefontface=\"false\" data-contrast=\"none\"> M, <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Primakov<\/span><span data-usefontface=\"false\" data-contrast=\"none\"> S, Woodruff HC, Chatterjee A, van <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Timmeren<\/span><span data-usefontface=\"false\" data-contrast=\"none\"> JE, <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Valli\u00e8res<\/span><span data-usefontface=\"false\" data-contrast=\"none\"> M, Hendriks LEL, Kraft J, <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Andratschke<\/span><span data-usefontface=\"false\" data-contrast=\"none\"> N, <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Braunstein SE, Morin O, Lambin P. <\/span><strong>Predicting Adverse Radiation Effects in Brain Tumors After Stereotactic Radiotherapy With Deep Learning and Handcrafted Radiomics<\/strong><span data-usefontface=\"false\" data-contrast=\"none\">. Front <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Oncol<\/span><span data-usefontface=\"false\" data-contrast=\"none\">. 2022 Jul 13;12:920393. <\/span><a href=\"https:\/\/www.frontiersin.org\/journals\/oncology\/articles\/10.3389\/fonc.2022.920393\/full\"><span data-usefontface=\"false\" data-contrast=\"none\">doi<\/span><\/a><span data-usefontface=\"false\" data-contrast=\"none\">:10.3389\/fonc.2022.920393. PMID: 35912214; PMCID: PMC9326101.<\/span>\u200b<\/p>\n<p style=\"text-align: left;\" data-ccp-props=\"{&quot;335551550&quot;:1,&quot;335551620&quot;:1,&quot;335559683&quot;:0,&quot;335559685&quot;:0,&quot;335559731&quot;:0,&quot;335559737&quot;:0,&quot;335562764&quot;:2,&quot;335562765&quot;:0.9,&quot;335562766&quot;:4,&quot;335562767&quot;:10,&quot;335562768&quot;:4,&quot;335562769&quot;:0}\"><span data-usefontface=\"false\" data-contrast=\"none\">Ibrahim A, <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Barufaldi<\/span><span data-usefontface=\"false\" data-contrast=\"none\"> B, <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Refaee<\/span><span data-usefontface=\"false\" data-contrast=\"none\"> T, Silva <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Filho<\/span><span data-usefontface=\"false\" data-contrast=\"none\"> TM, <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Acciavatti<\/span><span data-usefontface=\"false\" data-contrast=\"none\"> RJ, <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Salahuddin<\/span><span data-usefontface=\"false\" data-contrast=\"none\"> Z, <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Hustinx<\/span><span data-usefontface=\"false\" data-contrast=\"none\"> R, <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Mottaghy<\/span><span data-usefontface=\"false\" data-contrast=\"none\"> FM, <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Maidment<\/span><span data-usefontface=\"false\" data-contrast=\"none\"> ADA, Lambin P. <\/span><strong>MaasPenn Radiomics Reproducibility Score: A Novel Quantitative Measure for Evaluating the Reproducibility of CT-Based Handcrafted Radiomic <\/strong><span data-usefontface=\"false\" data-contrast=\"none\"><strong>Features.<\/strong> Cancers (Basel). 2022 Mar 22;14(7):1599. <\/span><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35406372\/\"><span data-usefontface=\"false\" data-contrast=\"none\">doi<\/span><\/a><span data-usefontface=\"false\" data-contrast=\"none\">:10.3390\/cancers14071599. PMID: 35406372; PMCID: PMC8997100.<\/span>\u200b<\/p>\n<p style=\"text-align: left;\" data-ccp-props=\"{&quot;335551550&quot;:1,&quot;335551620&quot;:1,&quot;335559683&quot;:0,&quot;335559685&quot;:0,&quot;335559731&quot;:0,&quot;335559737&quot;:0,&quot;335562764&quot;:2,&quot;335562765&quot;:0.9,&quot;335562766&quot;:4,&quot;335562767&quot;:10,&quot;335562768&quot;:4,&quot;335562769&quot;:0}\"><span data-usefontface=\"false\" data-contrast=\"none\">Griesinger F, Curigliano G, Thomas M, <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Subbiah<\/span><span data-usefontface=\"false\" data-contrast=\"none\"> V, <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Baik<\/span><span data-usefontface=\"false\" data-contrast=\"none\"> CS, Tan DSW, Lee DH, Misch D, <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Garralda<\/span><span data-usefontface=\"false\" data-contrast=\"none\"> E, Kim DW, van der <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Wekken<\/span><span data-usefontface=\"false\" data-contrast=\"none\"> AJ, <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Gainor<\/span> <span data-usefontface=\"false\" data-contrast=\"none\">JF, Paz-Ares L, Liu SV, <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Kalemkerian<\/span><span data-usefontface=\"false\" data-contrast=\"none\"> GP, <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Houvras<\/span><span data-usefontface=\"false\" data-contrast=\"none\"> Y, Bowles DW, Mansfield AS, Lin JJ, <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Smoljanovic<\/span><span data-usefontface=\"false\" data-contrast=\"none\"> V, Rahman A, Kong S, <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Zalutskaya<\/span><span data-usefontface=\"false\" data-contrast=\"none\"> A, <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Louie-Gao M, <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Boral<\/span><span data-usefontface=\"false\" data-contrast=\"none\"> AL, Mazi\u00e8res J. <\/span><strong>Safety and efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer including as first-line therapy: update from the ARROW trial<\/strong><span data-usefontface=\"false\" data-contrast=\"none\"><strong>.<\/strong> Ann <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Oncol<\/span><span data-usefontface=\"false\" data-contrast=\"none\">. 2022 Nov;33(11):1168-1178. <\/span><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35973665\/\"><span data-usefontface=\"false\" data-contrast=\"none\">doi<\/span><\/a><span data-usefontface=\"false\" data-contrast=\"none\">:10.1016\/j.annonc.2022.08.002. <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Epub<\/span><span data-usefontface=\"false\" data-contrast=\"none\"> 2022 Aug 13. <\/span><span data-usefontface=\"false\" data-contrast=\"none\">PMID: 35973665.<\/span><\/p>\n<p>&nbsp;<\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Vous trouverez ici les fiches d\u2019information les plus importantes, les publications et la biblioth\u00e8que vidoe sur le projet OPTIMA.<\/p>\n","protected":false},"author":1,"featured_media":4249,"parent":0,"menu_order":10,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":"","_links_to":"","_links_to_target":""},"class_list":["post-8086","page","type-page","status-publish","has-post-thumbnail","hentry"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.optima-oncology.eu\/fr\/wp-json\/wp\/v2\/pages\/8086","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.optima-oncology.eu\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.optima-oncology.eu\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.optima-oncology.eu\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.optima-oncology.eu\/fr\/wp-json\/wp\/v2\/comments?post=8086"}],"version-history":[{"count":11,"href":"https:\/\/www.optima-oncology.eu\/fr\/wp-json\/wp\/v2\/pages\/8086\/revisions"}],"predecessor-version":[{"id":8732,"href":"https:\/\/www.optima-oncology.eu\/fr\/wp-json\/wp\/v2\/pages\/8086\/revisions\/8732"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.optima-oncology.eu\/fr\/wp-json\/wp\/v2\/media\/4249"}],"wp:attachment":[{"href":"https:\/\/www.optima-oncology.eu\/fr\/wp-json\/wp\/v2\/media?parent=8086"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}